Track market-moving stories before they get noisy

Broadcom (AVGO +2.77%) has been one of the market's great winners, and I think it has another year in the tank.

Here is my prediction: Despite a sharp pullback this summer, Broadcom will beat the S&P 500 (^GSPC -0.14%) for the third year in a row. It crushed the index in 2024 with a total return north of 110%, followed that with roughly 51% in 2025, and I expect it to finish ahead of the market again in 2026.

Image source: Getty Images.

First, the bad news that scared investors: In June, Broadcom fell about 15% after its quarterly report. The results were actually excellent, with record revenue and AI chip sales up 143% from a year earlier, but its guidance for AI revenue came in just shy of Wall Street's expectations.

More unsettling, management acknowledged that Alphabet, a major customer, is diversifying its sources of custom chips. When a stock is priced for perfection, even small blemishes get punished, and that is what happened here to Broadcom.

Today's Change

(

2.77

%) $

10.70

Current Price

$

397.20

Why I think it beats the market anyway Look past the one-quarter wobble, and the growth story is intact. Broadcom designs the custom AI chips that giants like Alphabet and Meta Platforms use to build their own systems, and it dominates the networking gear that ties those chips together. Management has pointed toward a path to more than $100 billion in annual AI revenue, and its large software business adds steady, high-margin ballast that pure chipmakers lack.

Even after the June drop, the stock has returned roughly 36% over the past year, comfortably ahead of the S&P 500's low-20s gain. As long as the AI infrastructure build-out keeps expanding, and every signal says it will for years, Broadcom sits in the sweet spot.

Today's Change

(

-2.53

%) $

-16.29

Current Price

$

627.52

A risk to my prediction I will be honest about what could sink this call. Broadcom trades at a premium that leaves little room for disappointment, and the news that Alphabet is spreading its chip orders around is a genuine warning that Broadcom's biggest customers could eventually do more in-house. If AI spending cools or a key client pulls back, the stock could stumble and trail the index. A prediction with a deadline is always humbling.

My read is that the June pullback is an opportunity, not a signal to flee. Broadcom's combination of booming AI chips, dominant networking, and a cushioning software arm gives it the fundamentals to extend its market-beating streak to a third straight year. I could be wrong if the AI trade cools, so size the position for volatility, but I would not bet against this business just because it had one bumpy quarter.

Posted by Defense World Staff on Jul 23rd, 2026

ABN Amro Investment Solutions lessened its stake in Air Products and Chemicals, Inc. (NYSE:APD – Free Report) by 45.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,986 shares of the basic materials company’s stock after selling 12,387 shares during the quarter. ABN Amro Investment Solutions’ holdings in Air Products and Chemicals were worth $4,353,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the company. Oslo Pensjonsforsikring AS purchased a new stake in Air Products and Chemicals during the 1st quarter valued at $95,000. HORAN Wealth LLC raised its stake in shares of Air Products and Chemicals by 4.8% in the first quarter. HORAN Wealth LLC now owns 11,677 shares of the basic materials company’s stock worth $3,352,000 after purchasing an additional 538 shares during the last quarter. Baader Bank Aktiengesellschaft raised its stake in shares of Air Products and Chemicals by 0.7% in the first quarter. Baader Bank Aktiengesellschaft now owns 5,053 shares of the basic materials company’s stock worth $1,463,000 after purchasing an additional 37 shares during the last quarter. Long Road Investment Counsel LLC lifted its holdings in shares of Air Products and Chemicals by 2.0% during the first quarter. Long Road Investment Counsel LLC now owns 14,960 shares of the basic materials company’s stock valued at $4,346,000 after purchasing an additional 300 shares in the last quarter. Finally, Madison Asset Management LLC boosted its position in shares of Air Products and Chemicals by 43.9% during the first quarter. Madison Asset Management LLC now owns 40,611 shares of the basic materials company’s stock valued at $11,797,000 after buying an additional 12,384 shares during the last quarter. Institutional investors own 81.66% of the company’s stock.

Analyst Upgrades and Downgrades A number of equities analysts have weighed in on the company. Mizuho set a $345.00 target price on Air Products and Chemicals in a research report on Friday, May 1st. BMO Capital Markets upgraded shares of Air Products and Chemicals from a “market perform” rating to an “outperform” rating and set a $360.00 price target for the company in a research note on Friday, May 1st. Berenberg Bank set a $350.00 price objective on shares of Air Products and Chemicals and gave the company a “buy” rating in a report on Monday, April 20th. Wells Fargo & Company increased their price objective on shares of Air Products and Chemicals from $325.00 to $340.00 and gave the company an “overweight” rating in a research report on Friday, May 1st. Finally, Citigroup lifted their target price on shares of Air Products and Chemicals from $285.00 to $315.00 and gave the stock a “neutral” rating in a research report on Monday, April 13th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $326.88.

Read Our Latest Analysis on Air Products and Chemicals

Air Products and Chemicals Stock Performance Shares of NYSE APD opened at $297.14 on Thursday. Air Products and Chemicals, Inc. has a 12-month low of $229.11 and a 12-month high of $314.87. The firm has a market capitalization of $66.17 billion, a price-to-earnings ratio of 31.44, a price-to-earnings-growth ratio of 2.69 and a beta of 0.73. The company has a current ratio of 1.43, a quick ratio of 1.21 and a debt-to-equity ratio of 0.95. The firm has a 50 day moving average of $289.31 and a 200 day moving average of $285.05.

Air Products and Chemicals (NYSE:APD – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The basic materials company reported $3.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.06 by $0.14. Air Products and Chemicals had a net margin of 16.91% and a return on equity of 16.11%. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.07 billion. During the same quarter in the previous year, the firm posted $2.69 EPS. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. Air Products and Chemicals has set its FY 2026 guidance at 13.000-13.250 EPS and its Q3 2026 guidance at 3.250-3.350 EPS. On average, research analysts anticipate that Air Products and Chemicals, Inc. will post 13.22 earnings per share for the current year.

Insider Activity In related news, CFO Melissa N. Schaeffer sold 2,714 shares of the stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $303.76, for a total transaction of $824,404.64. Following the completion of the sale, the chief financial officer owned 14,212 shares in the company, valued at approximately $4,317,037.12. This trade represents a 16.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.88% of the company’s stock.

About Air Products and Chemicals (Free Report)

Air Products and Chemicals, Inc is a global supplier of industrial gases and related equipment and services, headquartered in Allentown, Pennsylvania. The company produces and delivers atmospheric gases such as oxygen, nitrogen and argon, as well as specialty and process gases used across a wide range of industrial applications. Air Products designs, builds and operates gas production facilities, merchant distribution networks and on-site gas systems for customers that require reliable, high-purity gases and integrated supply solutions.

The company’s product and service portfolio includes packaged and bulk gas supply, pipeline distribution, on-site generation, gas handling and storage equipment, and engineered systems for gas liquefaction and purification.

See Also Five stocks we like better than Air Products and Chemicals Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Air Products and Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Air Products and Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAndra AP fonden Purchases Shares of 103,900 CenterPoint Energy, Inc. $CNP

NEXT HEADLINE »AlpenGlobal Capital LLC Purchases Shares of 52,934 Amazon.com, Inc. $AMZN

Posted by Defense World Staff on Jul 23rd, 2026

Alamar Capital Management LLC purchased a new position in shares of Palo Alto Networks, Inc. (NASDAQ:PANW – Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 12,209 shares of the network technology company’s stock, valued at approximately $1,957,000. Palo Alto Networks comprises approximately 1.2% of Alamar Capital Management LLC’s portfolio, making the stock its 28th largest position.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of PANW. Janney Montgomery Scott LLC raised its position in shares of Palo Alto Networks by 15.0% during the first quarter. Janney Montgomery Scott LLC now owns 410,401 shares of the network technology company’s stock worth $65,796,000 after purchasing an additional 53,485 shares during the period. Aviva PLC lifted its holdings in shares of Palo Alto Networks by 5.4% during the 4th quarter. Aviva PLC now owns 568,804 shares of the network technology company’s stock valued at $104,774,000 after purchasing an additional 29,230 shares in the last quarter. Granite Islands Private Wealth LLC grew its position in shares of Palo Alto Networks by 43.6% in the 1st quarter. Granite Islands Private Wealth LLC now owns 15,342 shares of the network technology company’s stock valued at $2,453,000 after purchasing an additional 4,659 shares during the period. Peapack Gladstone Financial Corp grew its position in shares of Palo Alto Networks by 8.8% in the 4th quarter. Peapack Gladstone Financial Corp now owns 48,458 shares of the network technology company’s stock valued at $8,926,000 after purchasing an additional 3,926 shares during the period. Finally, Oak Thistle LLC bought a new stake in Palo Alto Networks during the 4th quarter worth approximately $1,554,000. 79.82% of the stock is owned by institutional investors and hedge funds.

Palo Alto Networks Price Performance NASDAQ:PANW opened at $335.28 on Thursday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.86 and a current ratio of 0.86. The stock’s 50-day simple moving average is $297.43 and its 200 day simple moving average is $215.80. The company has a market cap of $273.25 billion, a P/E ratio of 274.82, a P/E/G ratio of 12.70 and a beta of 0.91. Palo Alto Networks, Inc. has a 52-week low of $139.57 and a 52-week high of $368.80.

Palo Alto Networks (NASDAQ:PANW – Get Free Report) last issued its quarterly earnings results on Tuesday, June 2nd. The network technology company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.79 by $0.06. The firm had revenue of $3 billion during the quarter, compared to analysts’ expectations of $2.94 billion. Palo Alto Networks had a return on equity of 10.53% and a net margin of 7.95%.The business’s quarterly revenue was up 31.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.37 earnings per share. Palo Alto Networks has set its FY 2026 guidance at 3.770-3.790 EPS and its Q4 2026 guidance at 0.960-0.980 EPS. As a group, sell-side analysts forecast that Palo Alto Networks, Inc. will post 2.03 EPS for the current fiscal year.

Key Palo Alto Networks News Here are the key news stories impacting Palo Alto Networks this week:

Positive Sentiment: Analysts and commentators continue to highlight Palo Alto Networks as a key beneficiary of rising AI-driven cybersecurity spending, with Morgan Stanley saying sentiment on software stocks may be too negative and Barron’s arguing PANW could be a major winner in the new AI era. Article: Morgan Stanley Analysts Say Sentiment Has Gotten ‘Too Negative’ on Software Stocks. These Are Their Picks Positive Sentiment: Market watchers are also pointing to broader enterprise demand for cybersecurity as AI agents proliferate, which could support future security product spending and reinforce PANW’s growth narrative. Article: Citi Wealth CIO Warns “Infinite AI Agents” Will Accelerate Cybersecurity’s Share of Enterprise Spending Positive Sentiment: Palo Alto Networks announced it will acquire Embrace to extend its observability platform with Real User Monitoring and Synthetics, a move aimed at improving digital experience monitoring and AI-driven operations. Investors may see this as an expansion into a higher-value adjacent market. Article: Palo Alto Networks to Extend Leading Observability Platform with Innovative Digital Experience Monitoring Neutral Sentiment: Another brief note flagged PANW as a cybersecurity stock to follow, but did not add any new catalyst beyond the broader sector interest. Article: Cybersecurity Stocks To Follow Now – July 20th Negative Sentiment: Despite the upbeat long-term themes, one article noted PANW had slipped intraday, suggesting some investors are still taking profits or reacting to overall software sector weakness. Article: Palo Alto slips 3%: Why this analyst still sees it as a top cyber pick Insiders Place Their Bets In other Palo Alto Networks news, Director Helle Thorning-Schmidt sold 700 shares of the company’s stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $346.85, for a total value of $242,795.00. Following the transaction, the director directly owned 5,898 shares in the company, valued at $2,045,721.30. The trade was a 10.61% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Josh D. Paul sold 900 shares of the stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $345.00, for a total transaction of $310,500.00. Following the completion of the transaction, the chief accounting officer directly owned 79,644 shares in the company, valued at $27,477,180. The trade was a 1.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 101,239 shares of company stock worth $27,174,360 in the last quarter. Company insiders own 1.40% of the company’s stock.

Analyst Upgrades and Downgrades Several analysts have commented on PANW shares. Deutsche Bank Aktiengesellschaft raised their target price on shares of Palo Alto Networks from $220.00 to $350.00 and gave the stock a “buy” rating in a report on Wednesday, June 3rd. Truist Financial upped their target price on shares of Palo Alto Networks from $275.00 to $375.00 and gave the stock a “buy” rating in a research note on Wednesday, June 3rd. Wolfe Research reissued an “outperform” rating and issued a $320.00 price target on shares of Palo Alto Networks in a research note on Wednesday, June 3rd. Capital One Financial set a $421.00 price objective on Palo Alto Networks and gave the stock an “overweight” rating in a research report on Thursday, July 16th. Finally, BNP Paribas Exane increased their price objective on Palo Alto Networks from $330.00 to $380.00 and gave the stock an “outperform” rating in a report on Wednesday, July 1st. One research analyst has rated the stock with a Strong Buy rating, forty have given a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $331.48.

Read Our Latest Research Report on PANW

Palo Alto Networks Profile (Free Report)

Palo Alto Networks (NASDAQ: PANW) is a cybersecurity company founded in 2005 and headquartered in Santa Clara, California. The firm develops a broad suite of security products and services designed to prevent successful cyberattacks and protect enterprise networks, clouds, and endpoints. Built around a platform strategy, its offerings target threat prevention, detection, response and governance across hybrid and multi-cloud environments.

The company’s product portfolio includes next‑generation firewalls as a core on‑premises capability, alongside cloud‑delivered security services and software for securing public and private clouds.

Featured Stories Five stocks we like better than Palo Alto Networks Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Palo Alto Networks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palo Alto Networks and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEInvesco QQQ $QQQ Stock Holdings Decreased by American Financial Advisors LLC

NEXT HEADLINE »Northrop Grumman (NYSE:NOC) Price Target Cut to $550.00 by Analysts at TD Cowen

Posted by Defense World Staff on Jul 23rd, 2026

Alamar Capital Management LLC purchased a new position in shares of Spotify Technology (NYSE:SPOT – Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 4,802 shares of the company’s stock, valued at approximately $2,329,000. Spotify Technology makes up approximately 1.4% of Alamar Capital Management LLC’s holdings, making the stock its 18th largest holding.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. JPL Wealth Management LLC acquired a new stake in shares of Spotify Technology in the third quarter valued at $35,000. Kemnay Advisory Services Inc. bought a new position in Spotify Technology in the fourth quarter valued at $32,000. Newbridge Financial Services Group Inc. acquired a new stake in Spotify Technology in the 4th quarter valued at $35,000. Osbon Capital Management LLC acquired a new stake in Spotify Technology in the 4th quarter valued at $35,000. Finally, Wilmington Savings Fund Society FSB lifted its position in Spotify Technology by 85.7% during the 4th quarter. Wilmington Savings Fund Society FSB now owns 65 shares of the company’s stock worth $38,000 after buying an additional 30 shares in the last quarter. Institutional investors own 84.09% of the company’s stock.

Spotify Technology Stock Performance Spotify Technology stock opened at $474.72 on Thursday. The stock has a 50-day simple moving average of $479.93 and a 200 day simple moving average of $489.13. The stock has a market capitalization of $97.74 billion, a P/E ratio of 37.83, a PEG ratio of 1.22 and a beta of 1.56. Spotify Technology has a 52 week low of $405.00 and a 52 week high of $748.30.

Spotify Technology (NYSE:SPOT – Get Free Report) last released its quarterly earnings data on Tuesday, April 28th. The company reported $4.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.41 by $0.63. The firm had revenue of $5.25 billion for the quarter, compared to analyst estimates of $5.23 billion. Spotify Technology had a return on equity of 35.73% and a net margin of 15.56%.The business’s revenue for the quarter was up 8.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.07 earnings per share. Research analysts forecast that Spotify Technology will post 14.51 earnings per share for the current year.

Analyst Upgrades and Downgrades SPOT has been the subject of a number of recent research reports. KeyCorp reduced their price objective on shares of Spotify Technology from $745.00 to $680.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. JPMorgan Chase & Co. increased their price target on Spotify Technology from $600.00 to $650.00 and gave the company an “overweight” rating in a research report on Friday, May 22nd. Canaccord Genuity Group decreased their price target on Spotify Technology from $750.00 to $720.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Pivotal Research lowered their price target on Spotify Technology from $420.00 to $400.00 and set a “hold” rating on the stock in a research report on Wednesday, April 29th. Finally, Rosenblatt Securities dropped their price objective on Spotify Technology from $534.00 to $531.00 and set a “neutral” rating on the stock in a research note on Thursday, July 9th. Two analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $630.70.

Check Out Our Latest Research Report on Spotify Technology

Insiders Place Their Bets In other Spotify Technology news, Director Sven Hans Martin Lorentzon sold 35,380 shares of the stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $525.73, for a total value of $18,600,327.40. Following the transaction, the director directly owned 6,383 shares of the company’s stock, valued at $3,355,734.59. This represents a 84.72% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Christopher P. Marshall sold 2,650 shares of the firm’s stock in a transaction that occurred on Tuesday, May 26th. The stock was sold at an average price of $519.86, for a total transaction of $1,377,629.00. Following the sale, the director owned 4,039 shares of the company’s stock, valued at $2,099,714.54. This trade represents a 39.62% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 111,442 shares of company stock worth $54,757,553 in the last 90 days. Corporate insiders own 0.40% of the company’s stock.

Spotify Technology Company Profile (Free Report)

Spotify Technology is a digital audio streaming company best known for its on-demand music service and a growing portfolio of spoken-word content. Founded in Sweden in 2006 by Daniel Ek and Martin Lorentzon and launched commercially in 2008, the company offers a cross-platform app that enables users to discover, stream and organize music, podcasts and other audio. Its primary consumer products include a free, ad-supported tier and a paid Spotify Premium subscription that provides ad-free listening, offline playback and higher-quality audio streams.

Read More Five stocks we like better than Spotify Technology Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Spotify Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spotify Technology and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBessemer Group Inc. Buys 13,654 Shares of Vanguard Total International Stock ETF $VXUS

Posted by Defense World Staff on Jul 23rd, 2026

Allspring Global Investments Holdings LLC lifted its stake in shares of Automatic Data Processing, Inc. (NASDAQ:ADP – Free Report) by 12.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 53,157 shares of the business services provider’s stock after buying an additional 5,714 shares during the period. Allspring Global Investments Holdings LLC’s holdings in Automatic Data Processing were worth $10,699,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Imprint Wealth LLC acquired a new stake in shares of Automatic Data Processing during the 3rd quarter valued at $25,000. Cornerstone Financial Management LLC acquired a new position in Automatic Data Processing in the 4th quarter worth about $26,000. Bard Associates Inc. bought a new position in Automatic Data Processing in the fourth quarter valued at about $28,000. Whipplewood Advisors LLC raised its position in Automatic Data Processing by 2,740.0% in the first quarter. Whipplewood Advisors LLC now owns 142 shares of the business services provider’s stock valued at $29,000 after purchasing an additional 137 shares during the last quarter. Finally, Prosperity Bancshares Inc acquired a new stake in shares of Automatic Data Processing during the fourth quarter valued at about $33,000. 80.03% of the stock is currently owned by institutional investors.

Automatic Data Processing Stock Down 1.3% Automatic Data Processing stock opened at $243.12 on Thursday. The firm has a market cap of $97.18 billion, a price-to-earnings ratio of 22.68 and a beta of 0.83. Automatic Data Processing, Inc. has a 52-week low of $188.16 and a 52-week high of $315.98. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.04 and a current ratio of 1.04. The firm has a 50 day moving average price of $230.21 and a two-hundred day moving average price of $224.41.

Automatic Data Processing (NASDAQ:ADP – Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The business services provider reported $3.37 EPS for the quarter, beating analysts’ consensus estimates of $3.30 by $0.07. Automatic Data Processing had a net margin of 20.12% and a return on equity of 68.82%. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.85 billion. During the same period in the prior year, the firm posted $3.06 EPS. The company’s quarterly revenue was up 7.0% on a year-over-year basis. Automatic Data Processing has set its FY 2026 guidance at 11.010-11.110 EPS. Equities analysts predict that Automatic Data Processing, Inc. will post 11.08 EPS for the current year.

Key Stories Impacting Automatic Data Processing Here are the key news stories impacting Automatic Data Processing this week:

Positive Sentiment: Cantor Fitzgerald raised its price target on ADP to $295 from $244 and reiterated an overweight rating, signaling meaningful upside from current levels. Cantor Fitzgerald raises ADP price target Positive Sentiment: UBS also lifted its price target on ADP to $270 from $260 while maintaining a neutral view, adding to the stock’s recent analyst support. UBS raises ADP price target Positive Sentiment: Zacks noted that ADP has gained about 23% over the past three months, supported by margin expansion, strong earnings growth, steady dividends, and solid liquidity. ADP stock gains 23% in 3 months Positive Sentiment: ADP said its latest weekly private payroll estimate showed U.S. private employers added an average of 16,500 jobs per week for the four weeks ending July 4, reinforcing the company’s payroll data relevance. ADP National Employment Report preliminary estimate Neutral Sentiment: ADP’s June private-sector hiring report came in slightly below economists’ expectations, with 98,000 jobs added versus forecasts for 110,000, which may temper enthusiasm but does not indicate a major setback. ADP June private-sector hiring report Neutral Sentiment: ADP is expected to report earnings next week, and Zacks says the setup still looks favorable for a potential earnings beat, but this remains an anticipatory catalyst rather than a confirmed result. ADP earnings expectations ahead of release Negative Sentiment: MarketWatch noted ADP underperformed peers on Tuesday, suggesting some near-term relative weakness versus competitors. ADP underperforms competitors Analyst Ratings Changes Several analysts have recently weighed in on the company. Citigroup reduced their price target on Automatic Data Processing from $265.00 to $230.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. BMO Capital Markets cut their target price on shares of Automatic Data Processing from $281.00 to $234.00 and set a “market perform” rating on the stock in a research report on Tuesday, April 7th. Wells Fargo & Company boosted their target price on shares of Automatic Data Processing from $214.00 to $248.00 and gave the stock an “equal weight” rating in a report on Thursday, July 9th. Cantor Fitzgerald upped their price target on shares of Automatic Data Processing from $244.00 to $295.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, Morgan Stanley dropped their price target on shares of Automatic Data Processing from $311.00 to $274.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 28th. Three analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $256.00.

Get Our Latest Stock Analysis on Automatic Data Processing

Automatic Data Processing Profile (Free Report)

Automatic Data Processing, Inc (ADP) is a global provider of cloud-based human capital management (HCM) and payroll solutions. Founded in 1949 and headquartered in Roseland, New Jersey, ADP began as a payroll processing company and has evolved into a diversified provider of workforce management, HR, benefits administration, tax and compliance services, and analytics for employers of all sizes.

ADP’s product portfolio includes payroll processing and tax filing, time and attendance systems, benefits administration, talent management, and HR outsourcing.

See Also Five stocks we like better than Automatic Data Processing Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play Want to see what other hedge funds are holding ADP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Automatic Data Processing, Inc. (NASDAQ:ADP – Free Report).

Receive News & Ratings for Automatic Data Processing Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Automatic Data Processing and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmerican Investment Services Inc. Decreases Holdings in Verizon Communications Inc. $VZ

NEXT HEADLINE »Wintrust Financial Corporation $WTFC Stock Holdings Increased by California Public Employees Retirement System

Posted by Defense World Staff on Jul 23rd, 2026

AR Asset Management Inc. grew its holdings in shares of Chubb Limited (NYSE:CB – Free Report) by 16.0% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 17,285 shares of the financial services provider’s stock after purchasing an additional 2,379 shares during the period. Chubb makes up approximately 1.1% of AR Asset Management Inc.’s holdings, making the stock its 27th largest position. AR Asset Management Inc.’s holdings in Chubb were worth $5,634,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in CB. Spire Wealth Management boosted its stake in Chubb by 490.5% during the 4th quarter. Spire Wealth Management now owns 8,615 shares of the financial services provider’s stock valued at $2,689,000 after purchasing an additional 7,156 shares during the last quarter. Chesley Taft & Associates LLC raised its stake in shares of Chubb by 7.4% in the fourth quarter. Chesley Taft & Associates LLC now owns 102,427 shares of the financial services provider’s stock worth $31,970,000 after purchasing an additional 7,043 shares during the last quarter. Pallas Capital Advisors LLC lifted its holdings in shares of Chubb by 42.3% during the fourth quarter. Pallas Capital Advisors LLC now owns 14,243 shares of the financial services provider’s stock valued at $4,446,000 after purchasing an additional 4,233 shares in the last quarter. Janney Montgomery Scott LLC lifted its holdings in shares of Chubb by 1.7% during the first quarter. Janney Montgomery Scott LLC now owns 315,893 shares of the financial services provider’s stock valued at $102,959,000 after purchasing an additional 5,225 shares in the last quarter. Finally, waypoint wealth counsel boosted its position in shares of Chubb by 76.4% during the fourth quarter. waypoint wealth counsel now owns 4,118 shares of the financial services provider’s stock valued at $1,285,000 after buying an additional 1,784 shares during the last quarter. 83.81% of the stock is owned by institutional investors.

Chubb Stock Performance NYSE:CB opened at $343.42 on Thursday. The stock has a 50-day simple moving average of $334.18 and a two-hundred day simple moving average of $326.56. Chubb Limited has a 52-week low of $264.10 and a 52-week high of $365.29. The company has a debt-to-equity ratio of 0.20, a quick ratio of 0.28 and a current ratio of 0.28. The firm has a market capitalization of $133.20 billion, a PE ratio of 12.15, a P/E/G ratio of 1.84 and a beta of 0.40.

Chubb (NYSE:CB – Get Free Report) last posted its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $7.26 EPS for the quarter, topping the consensus estimate of $6.78 by $0.48. Chubb had a return on equity of 14.55% and a net margin of 18.10%.The firm had revenue of $14.71 billion for the quarter, compared to the consensus estimate of $15.07 billion. During the same quarter last year, the company earned $6.14 earnings per share. The business’s revenue for the quarter was up 3.6% compared to the same quarter last year. Analysts forecast that Chubb Limited will post 26.77 EPS for the current year.

Chubb Increases Dividend The company also recently announced a quarterly dividend, which was paid on Thursday, July 2nd. Investors of record on Friday, June 12th were issued a $1.02 dividend. The ex-dividend date of this dividend was Friday, June 12th. This represents a $4.08 annualized dividend and a yield of 1.2%. This is a positive change from Chubb’s previous quarterly dividend of $0.97. Chubb’s payout ratio is currently 14.41%.

Trending Headlines about Chubb Here are the key news stories impacting Chubb this week:

Positive Sentiment: Chubb beat Q2 EPS estimates, reporting core operating income of $7.26 per share versus expectations, with earnings up sharply from a year ago. Article Title Positive Sentiment: Underwriting remained strong, with the P&C combined ratio at 83.8%, catastrophe losses easing, and record investment income helping support results. Article Title Positive Sentiment: Several Wall Street firms turned constructive, including Citizens JMP reaffirming an outperform rating with a $400 target and JPMorgan lifting its target to $370, signaling meaningful upside from current levels. Article Title Neutral Sentiment: Some analysts still flagged softer property-casualty market conditions and weakness in major account premiums, which could temper near-term growth expectations. Article Title Negative Sentiment: Revenue came in below consensus, and the market appears to be focusing more on slower premium growth than on the earnings beat, contributing to the stock’s pullback. Article Title Analyst Ratings Changes A number of equities research analysts have issued reports on the company. UBS Group boosted their price target on Chubb from $340.00 to $369.00 and gave the company a “neutral” rating in a research note on Wednesday, July 8th. Citigroup reiterated a “market outperform” rating on shares of Chubb in a research note on Wednesday. Atlantic Securities set a $301.00 price objective on shares of Chubb in a report on Wednesday, July 15th. Mizuho boosted their target price on shares of Chubb from $335.00 to $352.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. Finally, JPMorgan Chase & Co. upped their target price on shares of Chubb from $340.00 to $370.00 and gave the company a “neutral” rating in a report on Monday. Two equities research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Chubb presently has a consensus rating of “Hold” and a consensus target price of $360.18.

Read Our Latest Stock Analysis on Chubb

Insider Buying and Selling In other Chubb news, COO John W. Keogh sold 23,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $321.51, for a total transaction of $7,394,730.00. Following the sale, the chief operating officer owned 203,322 shares in the company, valued at approximately $65,370,056.22. This trade represents a 10.16% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.37% of the company’s stock.

Chubb Profile (Free Report)

Chubb is a global property and casualty insurance company that underwrites a broad range of commercial and personal insurance products and related services. Its offerings include commercial property and casualty coverage, specialty liability, professional and management liability, cyber and technology insurance, marine and energy, surety, accident and health solutions, and high-net-worth personal lines such as homeowners, auto and valuables protection. Chubb serves businesses, individuals and institutions with tailored underwriting and risk-transfer solutions across multiple industry sectors.

In addition to core underwriting, Chubb provides risk engineering, loss control, claims management and risk consulting services intended to reduce loss severity and help clients manage exposures.

Featured Articles Five stocks we like better than Chubb Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play Want to see what other hedge funds are holding CB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chubb Limited (NYSE:CB – Free Report).

Receive News & Ratings for Chubb Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chubb and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAndra AP fonden Cuts Stock Position in The Progressive Corporation $PGR

NEXT HEADLINE »AR Asset Management Inc. Sells 4,000 Shares of Astrazeneca Plc $AZN

Assetmark Inc. lessened its stake in The Allstate Corporation (NYSE:ALL – Free Report) by 71.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 17,354 shares of the insurance provider’s stock after selling 42,801 shares during the period. Assetmark Inc.’s holdings in Allstate were worth $3,598,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. State Street Corp raised its holdings in shares of Allstate by 3.7% in the 4th quarter. State Street Corp now owns 12,297,551 shares of the insurance provider’s stock valued at $2,571,600,000 after buying an additional 438,034 shares during the period. GQG Partners LLC lifted its stake in Allstate by 36.0% during the 4th quarter. GQG Partners LLC now owns 5,488,560 shares of the insurance provider’s stock worth $1,142,449,000 after acquiring an additional 1,452,993 shares in the last quarter. Franklin Resources Inc. boosted its holdings in Allstate by 29.2% during the 4th quarter. Franklin Resources Inc. now owns 5,007,549 shares of the insurance provider’s stock valued at $1,042,321,000 after acquiring an additional 1,131,172 shares during the period. Boston Partners boosted its holdings in Allstate by 14.9% during the 3rd quarter. Boston Partners now owns 3,050,780 shares of the insurance provider’s stock valued at $654,652,000 after acquiring an additional 395,195 shares during the period. Finally, Raymond James Financial Inc. grew its position in Allstate by 3.3% in the 2nd quarter. Raymond James Financial Inc. now owns 2,793,645 shares of the insurance provider’s stock valued at $562,388,000 after acquiring an additional 88,620 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Wall Street Analysts Forecast Growth A number of brokerages have issued reports on ALL. Barclays boosted their price target on shares of Allstate from $203.00 to $213.00 and gave the stock an “underweight” rating in a research note on Tuesday, July 7th. Cantor Fitzgerald lifted their price objective on shares of Allstate from $236.00 to $242.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. Evercore set a $240.00 target price on shares of Allstate in a research note on Friday, July 10th. Morgan Stanley increased their target price on shares of Allstate from $215.00 to $240.00 and gave the stock an “equal weight” rating in a report on Monday, July 6th. Finally, Roth Capital reissued a “buy” rating and issued a $275.00 price target on shares of Allstate in a research report on Friday, July 17th. Three research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $254.80.

Check Out Our Latest Report on Allstate

Insiders Place Their Bets In other news, insider Mark Q. Prindiville sold 1,550 shares of Allstate stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $216.27, for a total transaction of $335,218.50. Following the sale, the insider owned 27,558 shares in the company, valued at approximately $5,959,968.66. The trade was a 5.32% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Mario Rizzo sold 18,578 shares of the business’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $218.80, for a total value of $4,064,866.40. Following the completion of the sale, the chief operating officer directly owned 82,227 shares of the company’s stock, valued at $17,991,267.60. The trade was a 18.43% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 22,353 shares of company stock valued at $4,851,560. 1.55% of the stock is currently owned by insiders.

Allstate Stock Performance Shares of ALL opened at $252.10 on Thursday. The company has a market capitalization of $64.90 billion, a price-to-earnings ratio of 5.56, a price-to-earnings-growth ratio of 0.43 and a beta of 0.16. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.25. The Allstate Corporation has a 52-week low of $188.08 and a 52-week high of $257.67. The stock has a 50 day moving average price of $229.54 and a 200 day moving average price of $215.33.

Allstate (NYSE:ALL – Get Free Report) last posted its earnings results on Wednesday, April 29th. The insurance provider reported $10.65 EPS for the quarter, beating analysts’ consensus estimates of $7.31 by $3.34. Allstate had a net margin of 17.81% and a return on equity of 42.66%. The firm had revenue of $16.94 billion for the quarter, compared to the consensus estimate of $15.24 billion. During the same period last year, the firm posted $3.53 EPS. The company’s revenue was up 3.0% on a year-over-year basis. Research analysts predict that The Allstate Corporation will post 30.51 EPS for the current fiscal year.

Allstate Dividend Announcement The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Monday, August 31st will be issued a dividend of $1.08 per share. The ex-dividend date of this dividend is Monday, August 31st. This represents a $4.32 annualized dividend and a dividend yield of 1.7%. Allstate’s dividend payout ratio (DPR) is presently 9.53%.

About Allstate (Free Report)

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.

Read More Five stocks we like better than Allstate Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.

Posted by Defense World Staff on Jul 23rd, 2026

California Public Employees Retirement System cut its stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 2.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 120,619 shares of the medical equipment provider’s stock after selling 3,016 shares during the period. California Public Employees Retirement System owned about 0.17% of Align Technology worth $20,678,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Sequoia Financial Advisors LLC increased its stake in shares of Align Technology by 320.1% in the 4th quarter. Sequoia Financial Advisors LLC now owns 7,986 shares of the medical equipment provider’s stock worth $1,247,000 after purchasing an additional 6,085 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in Align Technology by 35,513.8% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 545,604 shares of the medical equipment provider’s stock worth $85,196,000 after purchasing an additional 544,072 shares during the period. Polianta Ltd purchased a new position in Align Technology during the fourth quarter valued at $1,623,000. Wealth Enhancement Advisory Services LLC lifted its position in Align Technology by 63.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 25,343 shares of the medical equipment provider’s stock valued at $4,282,000 after purchasing an additional 9,792 shares in the last quarter. Finally, Hunter Perkins Capital Management LLC grew its holdings in Align Technology by 383.1% during the fourth quarter. Hunter Perkins Capital Management LLC now owns 43,842 shares of the medical equipment provider’s stock valued at $6,846,000 after purchasing an additional 34,767 shares during the period. 88.43% of the stock is owned by institutional investors.

Align Technology Stock Down 2.8% Shares of Align Technology stock opened at $172.46 on Thursday. The company has a market capitalization of $12.35 billion, a price-to-earnings ratio of 28.94, a PEG ratio of 1.82 and a beta of 1.67. The stock’s 50-day simple moving average is $172.96 and its 200-day simple moving average is $174.98. Align Technology, Inc. has a 52 week low of $122.00 and a 52 week high of $208.30.

Align Technology (NASDAQ:ALGN – Get Free Report) last released its earnings results on Wednesday, April 29th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.26 by $0.32. The firm had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Align Technology had a return on equity of 15.82% and a net margin of 10.50%.The firm’s revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the business posted $2.13 earnings per share. On average, equities analysts expect that Align Technology, Inc. will post 9.48 earnings per share for the current year.

Align Technology declared that its board has approved a stock repurchase program on Wednesday, April 29th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the medical equipment provider to buy up to 1.6% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

Analyst Ratings Changes ALGN has been the subject of a number of analyst reports. Weiss Ratings upgraded Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Zacks Research cut Align Technology from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 16th. Evercore boosted their price objective on Align Technology from $200.00 to $220.00 in a research note on Thursday, April 30th. Piper Sandler increased their target price on shares of Align Technology from $220.00 to $235.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Finally, Leerink Partners raised their target price on shares of Align Technology from $225.00 to $230.00 in a research note on Thursday, April 30th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Align Technology currently has an average rating of “Moderate Buy” and an average target price of $206.07.

Check Out Our Latest Analysis on ALGN

About Align Technology (Free Report)

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.

Featured Stories Five stocks we like better than Align Technology Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBoston Common Asset Management LLC Has $38.24 Million Stock Holdings in Broadcom Inc. $AVGO

NEXT HEADLINE »California Public Employees Retirement System Sells 13,519 Shares of Flutter Entertainment PLC $FLUT

Posted by Defense World Staff on Jul 23rd, 2026

Andra AP fonden lessened its holdings in shares of Cloudflare, Inc. (NYSE:NET – Free Report) by 30.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,456 shares of the company’s stock after selling 14,475 shares during the period. Andra AP fonden’s holdings in Cloudflare were worth $6,903,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of NET. Cassaday & Co Wealth Management LLC acquired a new stake in Cloudflare in the 1st quarter valued at about $53,000. Florida Financial Advisors LLC boosted its holdings in shares of Cloudflare by 22.4% during the 1st quarter. Florida Financial Advisors LLC now owns 5,611 shares of the company’s stock worth $1,158,000 after purchasing an additional 1,025 shares during the last quarter. Earned Wealth Advisors LLC grew its position in shares of Cloudflare by 2.9% in the first quarter. Earned Wealth Advisors LLC now owns 2,119 shares of the company’s stock valued at $437,000 after purchasing an additional 60 shares in the last quarter. Hollencrest Capital Management grew its position in shares of Cloudflare by 153.9% in the first quarter. Hollencrest Capital Management now owns 358 shares of the company’s stock valued at $74,000 after purchasing an additional 217 shares in the last quarter. Finally, Meeder Advisory Services Inc. grew its position in shares of Cloudflare by 14.9% in the first quarter. Meeder Advisory Services Inc. now owns 8,155 shares of the company’s stock valued at $1,683,000 after purchasing an additional 1,058 shares in the last quarter. Institutional investors and hedge funds own 82.68% of the company’s stock.

Cloudflare Trading Down 1.3% Shares of Cloudflare stock opened at $268.86 on Thursday. The stock has a 50 day moving average of $241.16 and a 200 day moving average of $211.56. The company has a debt-to-equity ratio of 1.29, a quick ratio of 1.96 and a current ratio of 1.96. The firm has a market capitalization of $95.04 billion, a price-to-earnings ratio of -1,075.46, a PEG ratio of 277.55 and a beta of 1.67. Cloudflare, Inc. has a fifty-two week low of $158.83 and a fifty-two week high of $291.00.

Cloudflare (NYSE:NET – Get Free Report) last posted its earnings results on Thursday, May 7th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Cloudflare had a negative return on equity of 5.65% and a negative net margin of 3.72%.The company had revenue of $639.75 million for the quarter, compared to the consensus estimate of $620.83 million. During the same quarter in the previous year, the business earned $0.16 earnings per share. The company’s revenue for the quarter was up 33.5% on a year-over-year basis. Cloudflare has set its FY 2026 guidance at 1.190-1.200 EPS and its Q2 2026 guidance at 0.270-0.270 EPS. As a group, research analysts predict that Cloudflare, Inc. will post 0.02 earnings per share for the current year.

Wall Street Analysts Forecast Growth A number of brokerages recently commented on NET. Sanford C. Bernstein reiterated a “market perform” rating and set a $136.00 price objective on shares of Cloudflare in a research report on Wednesday, June 10th. Wells Fargo & Company upped their target price on Cloudflare from $270.00 to $300.00 and gave the company an “overweight” rating in a report on Monday. Benchmark downgraded Cloudflare to an “underperform” rating in a research note on Tuesday, July 7th. Barclays lifted their price target on Cloudflare from $250.00 to $300.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Finally, Mizuho boosted their price target on shares of Cloudflare from $260.00 to $310.00 and gave the company an “outperform” rating in a research report on Wednesday, July 15th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $258.59.

Get Our Latest Stock Analysis on Cloudflare

Insider Transactions at Cloudflare In related news, Director Mark J. Hawkins sold 133 shares of the stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $249.00, for a total transaction of $33,117.00. Following the transaction, the director owned 10,765 shares of the company’s stock, valued at approximately $2,680,485. This represents a 1.22% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Matthew Prince sold 52,383 shares of the firm’s stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $247.28, for a total value of $12,953,268.24. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 564,903 shares of company stock worth $127,356,194. 10.66% of the stock is owned by corporate insiders.

About Cloudflare (Free Report)

Cloudflare, Inc is a global web infrastructure and security company that provides a suite of services designed to improve the performance, reliability and security of internet properties. Its core offerings include a content delivery network (CDN), distributed denial-of-service (DDoS) protection, managed DNS, and a web application firewall (WAF). Cloudflare also provides tools for bot management, SSL/TLS, load balancing and rate limiting to help organizations maintain uptime and protect web applications from attack.

In addition to traditional edge and security services, Cloudflare has expanded into edge computing and developer platforms.

Featured Stories Five stocks we like better than Cloudflare Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Cloudflare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cloudflare and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBank of New York Mellon Corp Increases Stock Holdings in Franklin U.S. Core Bond ETF $FLCB

NEXT HEADLINE »Allspring Global Investments Holdings LLC Trims Position in Expedia Group, Inc. $EXPE

Posted by Defense World Staff on Jul 23rd, 2026

Bank of New York Mellon Corp decreased its position in Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 2.8% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,302,043 shares of the biopharmaceutical company’s stock after selling 37,662 shares during the quarter. Bank of New York Mellon Corp owned approximately 0.23% of Royalty Pharma worth $62,459,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Phillips Wealth Planners LLC grew its stake in shares of Royalty Pharma by 1.9% in the fourth quarter. Phillips Wealth Planners LLC now owns 13,113 shares of the biopharmaceutical company’s stock worth $521,000 after purchasing an additional 242 shares during the last quarter. Strs Ohio raised its position in Royalty Pharma by 2.8% during the 4th quarter. Strs Ohio now owns 9,318 shares of the biopharmaceutical company’s stock valued at $360,000 after purchasing an additional 252 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd raised its position in Royalty Pharma by 0.6% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 43,287 shares of the biopharmaceutical company’s stock valued at $1,673,000 after purchasing an additional 255 shares during the last quarter. Cary Street Partners Financial LLC lifted its holdings in Royalty Pharma by 1.1% in the 4th quarter. Cary Street Partners Financial LLC now owns 24,405 shares of the biopharmaceutical company’s stock worth $943,000 after buying an additional 260 shares during the period. Finally, Private Trust Co. NA lifted its holdings in Royalty Pharma by 52.9% in the 4th quarter. Private Trust Co. NA now owns 832 shares of the biopharmaceutical company’s stock worth $32,000 after buying an additional 288 shares during the period. Hedge funds and other institutional investors own 54.35% of the company’s stock.

Insider Buying and Selling at Royalty Pharma In related news, Director Gregory Norden sold 3,045 shares of Royalty Pharma stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $53.00, for a total transaction of $161,385.00. Following the completion of the transaction, the director directly owned 191,803 shares of the company’s stock, valued at $10,165,559. This trade represents a 1.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Terrance P. Coyne sold 64,399 shares of the business’s stock in a transaction dated Tuesday, May 26th. The stock was sold at an average price of $53.98, for a total transaction of $3,476,258.02. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 427,800 shares of company stock valued at $23,333,723 in the last quarter. 18.84% of the stock is owned by insiders.

Royalty Pharma Trading Up 0.5% NASDAQ RPRX opened at $58.72 on Thursday. The company has a quick ratio of 2.66, a current ratio of 2.66 and a debt-to-equity ratio of 0.86. Royalty Pharma PLC has a twelve month low of $34.08 and a twelve month high of $59.44. The firm has a market capitalization of $33.81 billion, a PE ratio of 39.95, a P/E/G ratio of 10.35 and a beta of 0.43. The stock’s 50 day moving average is $55.37 and its 200 day moving average is $49.00.

Royalty Pharma (NASDAQ:RPRX – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The biopharmaceutical company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.08. The company had revenue of $630.58 million for the quarter, compared to analysts’ expectations of $881.69 million. Royalty Pharma had a return on equity of 29.25% and a net margin of 33.88%. Research analysts forecast that Royalty Pharma PLC will post 5.18 earnings per share for the current fiscal year.

Royalty Pharma Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 10th. Investors of record on Friday, August 14th will be paid a $0.235 dividend. This represents a $0.94 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Friday, August 14th. Royalty Pharma’s dividend payout ratio (DPR) is presently 63.95%.

Wall Street Analysts Forecast Growth Several research firms have recently issued reports on RPRX. Weiss Ratings cut Royalty Pharma from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, May 15th. Wall Street Zen raised Royalty Pharma from a “buy” rating to a “strong-buy” rating in a research note on Saturday, May 9th. JPMorgan Chase & Co. lifted their price target on shares of Royalty Pharma from $50.00 to $58.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Citigroup boosted their price objective on shares of Royalty Pharma from $50.00 to $66.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Finally, Morgan Stanley upped their price objective on shares of Royalty Pharma from $61.00 to $63.00 and gave the stock an “overweight” rating in a report on Friday, April 10th. Seven analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Royalty Pharma has an average rating of “Buy” and an average target price of $56.57.

View Our Latest Stock Analysis on RPRX

Royalty Pharma Profile (Free Report)

Royalty Pharma plc is a specialty finance company that acquires biopharmaceutical royalty interests and provides non-dilutive financing to drug developers and rights holders. The firm purchases future royalty streams, milestone-contingent payments and other revenue rights linked to approved and late-stage pharmaceutical and biotechnology products. By paying upfront consideration for these rights, Royalty Pharma seeks to generate long-term cash flows tied to the commercial performance of a diversified portfolio of medicines.

The company’s transaction structures include outright royalty purchases, structured financings and milestone arrangements tailored to the needs of innovator companies, academic institutions and investors.

Featured Articles Five stocks we like better than Royalty Pharma Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play Want to see what other hedge funds are holding RPRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Royalty Pharma PLC (NASDAQ:RPRX – Free Report).

Receive News & Ratings for Royalty Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Royalty Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEFifth Third Bancorp Buys 19,655 Shares of ONE Gas, Inc. $OGS

NEXT HEADLINE »Streaming Stocks To Watch Now – July 21st

Posted by Defense World Staff on Jul 23rd, 2026

Andra AP fonden lowered its holdings in shares of Invitation Home (NYSE:INVH – Free Report) by 31.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 170,472 shares of the company’s stock after selling 77,228 shares during the period. Andra AP fonden’s holdings in Invitation Home were worth $4,236,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of INVH. AQR Capital Management LLC boosted its position in shares of Invitation Home by 67.4% during the 1st quarter. AQR Capital Management LLC now owns 74,426 shares of the company’s stock valued at $2,589,000 after acquiring an additional 29,962 shares in the last quarter. Empowered Funds LLC raised its position in Invitation Home by 10.7% in the first quarter. Empowered Funds LLC now owns 13,324 shares of the company’s stock worth $464,000 after purchasing an additional 1,290 shares in the last quarter. Sivia Capital Partners LLC acquired a new position in Invitation Home in the second quarter worth about $287,000. Cetera Investment Advisers lifted its stake in Invitation Home by 8.5% during the second quarter. Cetera Investment Advisers now owns 19,412 shares of the company’s stock worth $637,000 after purchasing an additional 1,528 shares during the period. Finally, Cresset Asset Management LLC lifted its stake in Invitation Home by 5.5% during the second quarter. Cresset Asset Management LLC now owns 15,646 shares of the company’s stock worth $515,000 after purchasing an additional 809 shares during the period. Institutional investors own 96.79% of the company’s stock.

Invitation Home Price Performance Shares of INVH opened at $29.53 on Thursday. The company has a quick ratio of 0.02, a current ratio of 0.02 and a debt-to-equity ratio of 0.50. Invitation Home has a twelve month low of $24.25 and a twelve month high of $32.67. The stock has a market capitalization of $17.54 billion, a P/E ratio of 31.08, a P/E/G ratio of 3.50 and a beta of 0.84. The company has a 50 day moving average of $29.49 and a 200-day moving average of $27.55.

Invitation Home (NYSE:INVH – Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.18 by $0.08. The company had revenue of $579.00 million during the quarter, compared to the consensus estimate of $689.91 million. Invitation Home had a return on equity of 6.29% and a net margin of 20.88%.The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.48 EPS. Invitation Home has set its FY 2026 guidance at 1.900-1.980 EPS. As a group, equities research analysts forecast that Invitation Home will post 1.89 EPS for the current fiscal year.

Invitation Home Dividend Announcement The business also recently announced a quarterly dividend, which was paid on Friday, July 17th. Stockholders of record on Thursday, June 25th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date was Thursday, June 25th. Invitation Home’s dividend payout ratio is presently 126.32%.

Analyst Upgrades and Downgrades Several equities research analysts have recently weighed in on INVH shares. BMO Capital Markets upped their price objective on Invitation Home from $32.00 to $35.00 and gave the company a “market perform” rating in a research note on Monday, June 15th. Royal Bank Of Canada boosted their price target on Invitation Home from $28.00 to $30.00 and gave the company a “sector perform” rating in a research note on Friday, May 1st. Barclays upped their price target on Invitation Home from $32.00 to $36.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. Raymond James Financial raised Invitation Home from a “market perform” rating to an “outperform” rating and set a $32.00 price objective for the company in a report on Monday, May 18th. Finally, Evercore restated an “outperform” rating and issued a $32.00 target price on shares of Invitation Home in a research note on Friday, May 1st. Ten investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Invitation Home currently has an average rating of “Hold” and an average price target of $32.47.

Check Out Our Latest Stock Analysis on INVH

Invitation Home Company Profile (Free Report)

Invitation Homes (NYSE: INVH) is a real estate investment trust that specializes in the ownership, operation and leasing of single-family rental homes across the United States. The company focuses on acquiring suburban and urban-adjacent single-family residences and managing them as rental properties for households seeking professionally managed, long-term housing alternatives to traditional homeownership or multifamily rentals.

Operationally, Invitation Homes is involved in the full lifecycle of the single-family rental business: sourcing and acquiring homes, performing renovations and ongoing maintenance, marketing and leasing properties, and providing property management and resident services.

Featured Articles Five stocks we like better than Invitation Home Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Invitation Home Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invitation Home and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAMETEK, Inc. $AME Shares Purchased by Andra AP fonden

NEXT HEADLINE »Andra AP fonden Purchases Shares of 103,900 CenterPoint Energy, Inc. $CNP

The maker of spices and seasonings said the London listing would come in addition to its current listing on the New York Stock Exchange.

Raising Full-Year Net Sales and EPS guidance

, /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of innovative, high-quality injectable solutions and services, today announced its financial results for the second quarter of 2026.

Second-Quarter Summary (comparisons to prior-year period)

Net sales of $872.3 million increased 13.8%; organic growth was 12.7%. Diluted earnings per share ("EPS") of $2.15 increased 18.1%. Adjusted-diluted EPS of $2.37 increased 28.8%. Operating cash flow was $213.9 million. Capital expenditures were $85.9 million. Free cash flow (defined as operating cash flow less capital expenditures) was $128.0 million. During the first six months of 2026, the Company repurchased 1.8 million shares for $454.3 million at an average price of $258.03 per share under its share repurchase program that was announced in mid-February 2026. The Company also announced on July 21, 2026 that its Board of Directors declared a third-quarter 2026 dividend of $0.22 per share. Outlook for Full-Year and Third-Quarter 2026

Full-year 2026 net sales are expected to be in the range of $3.345 billion to $3.380 billion, up 8.8% to 10.0% reported and up 10.0% to 11.0% organic. Full-year 2026 adjusted-diluted EPS guidance increased to a range of $8.85 to $9.05. Third-quarter 2026 net sales are expected to be in the range of $820 million to $835 million, up 1.9% to 3.8% reported and up 7.0% to 8.9% organic. Third-quarter 2026 adjusted-diluted EPS guidance is expected to be in the range of $2.14 to $2.24. Eric M. Green, President, Chief Executive Officer and Chair of the Board, commented: "I am pleased to report strong second-quarter results, with net sales and adjusted EPS exceeding our expectations. Net sales increased 12.7% organically, driven by our High Value Product Components business which benefited from continued strength in Biologics, a favorable mix shift from HVP upgrades including Annex 1, and ongoing growth in GLP-1 elastomers.  The robust sales growth drove strong operating income margin expansion as compared to prior year. As a result of our team's strong execution in the second quarter and improved outlook, we are increasing our full-year 2026 guidance."

Proprietary Products Segment
Net sales of $722.6 million grew by 16.6% and increased 15.5% on an organic basis.

High-Value Product ("HVP") Components net sales of $424.1 million increased 19.4% and rose 18.4% on an organic basis. HVP Components accounted for 49% of total company net sales in the quarter. HVP Delivery Devices net sales of $131.2 million increased by 29.6%, and were up 29.2% on an organic basis. HVP Delivery Devices accounted for 15% of total company net sales in the quarter. Standard Products net sales of $167.3 million increased by 2.4% and rose 0.7% on an organic basis. Standard Products accounted for 19% of total company net sales this quarter. West Vantage Segment
Net sales of $149.7 million increased by 2.0% and rose 0.8% on an organic basis. West Vantage accounted for 17% of total company net sales in the quarter.

Full-Year 2026 Financial Guidance

The Company is increasing its full-year 2026 net sales guidance range to $3.345 billion to $3.380 billion, up from $3.295 billion to $3.350 billion. Reported net sales growth is anticipated to be in the range of 8.8% to 10.0%, and organic net sales growth is expected to be in the range of 10.0% to 11.0%. Net sales guidance includes an estimated full-year 2026 benefit of approximately 1 percentage point based on current foreign currency exchange rates. SmartDose® 3.5mL generated $55 million in net sales in the second half of 2025. These net sales are excluded going forward to calculate our organic net sales growth guidance. The Company is increasing its full-year 2026 adjusted-diluted EPS guidance range to $8.85 to $9.05, up from the previous range of $8.40 to $8.75. Capital spending guidance is unchanged from a range of $250 million to $275 million. Third-Quarter 2026 Financial Guidance

The Company is introducing its third-quarter 2026 net sales guidance range of $820 million to $835 million. Reported net sales growth is anticipated to be in the range of 1.9% to 3.8%, and organic net sales growth is expected to be in the range of 7.0% to 8.9%. Net sales guidance includes an estimated headwind of approximately 1 percentage point based on current foreign currency exchange rates. SmartDose® 3.5mL generated $30 million in net sales in the third quarter of 2025. These net sales are excluded going forward to calculate our organic net sales growth guidance. The Company is introducing its third-quarter 2026 adjusted-diluted EPS guidance range of $2.14 to $2.24. Second-Quarter 2026 Conference Call 
Management will host a conference call at 8 a.m. EDT today. The live webcast can be accessed in the "Investors" section of the Company's website by clicking here.

To participate in the Q&A portion of the conference call, please register in advance by clicking here.

Registered telephone participants will receive the dial-in number along with a unique PIN number that will enable them to ask questions on the call.

An accompanying slide presentation will be posted in the "Investors" section of the Company's website.

A replay of the webcast will be available on the Company's website for approximately 90 days after the event.

About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 26 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year. Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated $3.07 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included in the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

Daikyo®, Daikyo Crystal Zenith® and Daikyo CZ® are registered trademarks of Daikyo Seiko, Ltd. Daikyo Crystal Zenith technologies are licensed from Daikyo Seiko, Ltd. 

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the Company's expectations regarding future events, financial guidance and financial or operational performance. Forward-looking statements may be identified by words such as "believe," "expect," "intend," "estimate," "plan," "anticipate," "project," "forecast," "guidance," "target," "may," "will," "continue" and similar expressions.

These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For additional information regarding these risks as well as other risks, uncertainties and factors that could affect our forward-looking statements, please refer to Part I Item 1A, entitled "Risk Factors," of the Company's most recent Annual Report on Form 10-K and any amendments thereto, as well as the Company's most recently filed Quarterly Reports on Form 10-Q and other filings the Company makes with the Securities and Exchange Commission.

Forward-looking statements speak only as of the date of this press release. Except as required by law or regulation, West Pharmaceutical Services, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Non-U.S. GAAP Financial Measures
The Company reports its financial results in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). However, management also uses certain non-U.S. GAAP financial measures in evaluating our results of operations. Management believes that this information provides users with a valuable insight into our overall performance and financial position. As a result, this release contains certain non-GAAP financial measures, including organic net sales, adjusted-diluted EPS and adjusted operating profit. Organic net sales exclude the impact from acquisitions and/or divestitures and translate the current-period reported sales of subsidiaries whose functional currency is other than the U.S. Dollar at the applicable foreign currency exchange rates in effect during the comparable prior-year period. We may also refer to financial results, such as adjusted-diluted EPS and adjusted operating profit, that exclude the effects of unallocated items. The unallocated items are not representative of ongoing operations, and generally include restructuring and related charges, certain asset impairments, and other specifically identified income or expense items. These non-U.S. GAAP financial measures should be viewed in addition to, and not as an alternative for, the Company's results prepared in accordance with U.S. GAAP. A reconciliation of these non-U.S. GAAP measures to the comparable U.S. GAAP financial measures is included in the accompanying tables.

WEST PHARMACEUTICAL SERVICES, INC.

CONSOLIDATED STATEMENTS OF INCOME

(UNAUDITED)

(in millions, except per share data)

Three Months Ended
June 30,

Six Months Ended
June 30,

2026

2025

2026

2025

Net sales

$       872.3

100 %

$       766.5

100 %

$         1,717.2

100 %

$         1,464.5

100 %

Cost of goods and services sold

543.1

62

492.6

64

1,091.6

64

958.7

65

Gross profit

329.2

38

273.9

36

625.6

36

505.8

35

Research and development

19.7

2

19.1

2

35.5

2

35.4

2

Selling, general and administrative expenses

117.6

14

95.9

13

217.1

12

183.9

13

Other expense (income), net

12.8

1

5.2

1

16.8

1

25.8

2

Operating profit

179.1

21

153.7

20

356.2

21

260.7

18

Interest (income) expense, net

(1.2)

—

(3.5)

—

(4.4)

—

(7.2)

—

Other nonoperating expense (income)

0.2

—

0.2

—

0.4

—

0.4

—

Income before income taxes and equity
in net income of affiliated companies

180.1

21

157.0

20

360.2

21

267.5

18

Income tax expense

32.2

4

30.2

4

76.9

4

54.3

4

Equity in net income of affiliated companies

(6.1)

(1)

(5.0)

(1)

(9.5)

—

(8.4)

(1)

Net income

$       154.0

18 %

$       131.8

17 %

$  292.8

17 %

$ 221.6

15 %

Net income per share:

Basic

$ 2.17

$ 1.82

$   4.10

$  3.06

Diluted

$ 2.15

$ 1.82

$   4.07

$  3.05

Average common shares outstanding

70.8

72.2

71.4

72.3

Average shares assuming dilution

71.3

72.5

71.9

72.8

WEST PHARMACEUTICAL SERVICES

REPORTING SEGMENT INFORMATION

(UNAUDITED)

(in millions)

Three Months Ended

June 30,

Six Months Ended

June 30,

Net Sales:

2026

2025

2026

2025

Proprietary Products

$      722.6

$      619.8

$    1,416.9

$    1,182.8

West Vantage

149.7

146.7

300.3

281.7

Consolidated Total

$      872.3

$      766.5

$    1,717.2

$    1,464.5

Gross Profit:

Proprietary Products

$      308.0

$      248.3

$      581.1

$      458.5

West Vantage

21.2

25.6

44.5

47.3

Gross Profit

$      329.2

$      273.9

$      625.6

$      505.8

Gross Profit Margin

37.7 %

35.7 %

36.4 %

34.5 %

Operating Profit (Loss):

Proprietary Products

$      211.9

$      161.7

$      401.1

$      292.3

West Vantage

12.9

17.8

28.5

31.3

Stock-based compensation expense

(10.9)

(7.4)

(17.5)

(8.7)

General corporate costs

(34.8)

(18.4)

(55.9)

(54.2)

Reported Operating Profit

$      179.1

$      153.7

$      356.2

$      260.7

Reported Operating Profit Margin

20.5 %

20.1 %

20.7 %

17.8 %

Unallocated items

18.3

1.6

22.2

19.6

Adjusted Operating Profit

$      197.4

$      155.3

$      378.4

$      280.3

Adjusted Operating Profit Margin

22.6 %

20.3 %

22.0 %

19.1 %

WEST PHARMACEUTICAL SERVICES

RECONCILIATION OF NON-U.S. GAAP MEASURES (UNAUDITED)

Please refer to "Non-U.S. GAAP Financial Measures" for more information

(in millions, except per share data)

Reconciliation of Reported and Adjusted Operating Profit, Net Income and Diluted EPS

Three Months ended June 30, 2026

Operating

profit

Income

tax

expense

Net

income

Diluted

EPS

Reported (U.S. GAAP)

$179.1

$32.2

$154.0

$2.15

Unallocated Items:

Restructuring and other charges(1)

1.5

0.3

1.2

0.02

M&A activities, including SmartDose® 3.5mL sale(2)

6.4

1.5

4.9

0.07

Cost-method investment activity(3)

3.5

—

3.5

0.05

Amortization of acquisition-related intangible assets(4)

—

—

0.4

—

Other(5)

6.9

1.4

5.4

0.08

Adjusted (Non-U.S. GAAP)

$197.4

$35.4

$169.4

$2.37

Six Months ended June 30, 2026

Operating

profit

Income

tax

expense

Net

income

Diluted

EPS

Reported (U.S. GAAP)

$356.2

$76.9

$292.8

$4.07

Unallocated Items:

Restructuring and other charges(1)

2.9

(11.3)

14.2

0.20

M&A activities, including SmartDose® 3.5mL sale(2)

8.3

1.9

6.4

0.09

Cost-method investment activity(3)

3.5

—

3.5

0.05

Amortization of acquisition-related intangible assets(4)

—

—

0.9

0.01

Other(5)

7.5

1.6

5.9

0.08

Adjusted (Non-U.S. GAAP)

$378.4

$69.1

$323.7

$4.50

Three Months ended June 30, 2025

Operating

profit

Income

tax

expense

Net

income

Diluted

EPS

Reported (U.S. GAAP)

$153.7

$30.2

$131.8

$1.82

Unallocated items:

Restructuring and other charges(1)

1.6

0.4

1.2

0.02

Amortization of acquisition-related intangible assets(4)

—

—

0.5

—

Adjusted (Non-U.S. GAAP)

$155.3

$30.6

$133.5

$1.84

Six Months ended June 30, 2025

Operating

profit

Income

tax

expense

Net

income

Diluted

EPS

Reported (U.S. GAAP)

$260.7

$54.3

$221.6

$3.05

Unallocated items:

Restructuring and other charges(1)

19.4

2.4

17.0

0.23

Amortization of acquisition-related intangible assets(4)

0.2

—

1.1

0.01

Adjusted (Non-U.S. GAAP)

$280.3

$56.7

$239.7

$3.29

(1)

During the three and six months ended June 30, 2026, the Company recorded pre-tax charges of $1.5 million and $2.9 million, respectively, related to our two existing restructuring programs: (i) $1.0 million and $1.9 million, respectively, within other expense (income), related to acceleration of depreciation and lease costs in connection with the Company's January 2025 restructuring plan and (ii) $0.5 million and $1.0 million, respectively, within selling, general and administrative expenses, for professional services relating to our 2024 plan to optimize the legal structure of the Company and its subsidiaries. In addition, we recorded a one-time tax cost of $12.0 million associated with an internal legal entity restructuring which occurred in the first quarter of 2026. During the three and six months ended June 30, 2025, the Company recorded pre-tax charges of $1.6 million and $19.4 million, respectively, related to our two existing restructuring programs: (i) $0.2 million and $16.6 million, respectively, within other expense (income), related to severance, acceleration of depreciation and lease costs in connection with the Company's January 2025 restructuring plan and (ii) $1.4 million and $2.8 million, respectively, within selling, general and administrative expenses, for professional services relating to our 2024 plan to optimize the legal structure of the Company and its subsidiaries. In addition, we recorded income tax charges of $2.0 million in the first quarter of 2025, related primarily to withholding tax and capital gains incurred in executing our plan to optimize our legal structure.

(2)

During the three and six months ended June 30, 2026, the Company recorded pre-tax charges of $6.4 million and $8.3 million, respectively, related to M&A activities, including the Company's agreement to sell its SmartDose® 3.5mL On-Body Delivery System and associated facilities to AbbVie. The Company recorded $1.3 million and $2.2 million, respectively, of the charges within other expense (income), related to employee benefit costs in connection with the sale agreement. The Company recorded the remaining $5.1 million and $6.1 million, respectively, within selling, general and administrative expenses, relating to professional services in connection with the sale agreement and other M&A activities.

(3)

During the three and six months ended June 30, 2026, the Company recorded cost-method investment impairment charges of $3.5 million within other expense (income).

(4)

During the three and six months ended June 30, 2026, the Company recorded $0.4 million and $0.9 million, respectively, of amortization expense in association with an acquisition of increased ownership interest in Daikyo. During the three and six months ended June 30, 2025, the Company recorded $0.0 million and $0.2 million, respectively, of amortization expense within selling, general and administrative expenses associated with an intangible asset acquired during the second quarter of 2020. During the three and six months ended June 30, 2025, the Company recorded $0.5 million and $0.9 million, respectively, of amortization expense in association with an acquisition of increased ownership interest in Daikyo.

(5)

Other includes nonrecurring professional fees associated with various items including certain legal matters and our cybersecurity incident from May 2026. These charges are recorded within selling, general and administrative expenses.

WEST PHARMACEUTICAL SERVICES

RECONCILIATION OF NON-U.S. GAAP FINANCIAL MEASURES (UNAUDITED)

Please refer to "Non-U.S. GAAP Financial Measures" for more information

(in millions, except per share data)

Reconciliation of Reported Net Sales to Organic Net Sales by Segment (6)

Three Months Ended

June 30,

Reported Net Sales
(U.S. GAAP)

Percent
Change

Impact of
Currency

Organic Net Sales
Growth Rate (Decline)
(Non-U.S. GAAP) (6)

2026

2025

Proprietary Products

$722.6

$619.8

16.6 %

1.1 %

15.5 %

West Vantage

149.7

146.7

2.0 %

1.2 %

0.8 %

Total

$872.3

$766.5

13.8 %

1.1 %

12.7 %

Six Months Ended

June 30,

Reported Net Sales
(U.S. GAAP)

Percent
Change

Impact of
Currency

Organic Net Sales
Growth Rate (Decline)
(Non-U.S. GAAP) (6)

2026

2025

Proprietary Products

$1,416.9

$1,182.8

19.8 %

3.3 %

16.5 %

West Vantage

300.3

281.7

6.6 %

3.2 %

3.4 %

Total

$1,717.2

$1,464.5

17.3 %

3.4 %

13.9 %

Reconciliation of Proprietary Products Segment Organic Net Sales by Product Category (6)

Three Months Ended

June 30,

Reported Net Sales
(U.S. GAAP)

Percent
Change

Impact of
Currency

Organic Net Sales
Growth Rate (Decline)
(Non-U.S. GAAP) (6)

2026

2025

HVP Components

$424.1

$355.2

19.4 %

1.0 %

18.4 %

HVP Delivery Devices

131.2

101.2

29.6 %

0.4 %

29.2 %

Standard Products

167.3

163.4

2.4 %

1.7 %

0.7 %

Total Proprietary Products

$722.6

$619.8

16.6 %

1.1 %

15.5 %

Six Months Ended

June 30,

Reported Net Sales
(U.S. GAAP)

Percent
Change

Impact of
Currency

Organic Net Sales
Growth Rate (Decline)
(Non-U.S. GAAP) (6)

2026

2025

HVP Components

$833.4

$671.1

24.2 %

3.8 %

20.4 %

HVP Delivery Devices

254.8

197.0

29.3 %

1.0 %

28.3 %

Standard Products

328.7

314.7

4.4 %

3.8 %

0.6 %

Total Proprietary Products

$1,416.9

$1,182.8

19.8 %

3.3 %

16.5 %

Reconciliation of Proprietary Products Segment Organic Net Sales by Market Group (6)

Three Months Ended

June 30,

Reported Net Sales
(U.S. GAAP)

Percent
Change

Impact of
Currency

Organic Net Sales
Growth Rate (Decline)
(Non-U.S. GAAP) (6)

2026

2025

Biologics

$374.8

$287.7

30.3 %

1.1 %

29.2 %

Pharma

205.0

198.5

3.3 %

1.7 %

1.6 %

Generics

142.8

133.6

6.9 %

0.2 %

6.7 %

Total Proprietary Products

$722.6

$619.8

16.6 %

1.1 %

15.5 %

Six Months Ended

June 30,

Reported Net Sales
(U.S. GAAP)

Percent
Change

Impact of
Currency

Organic Net Sales
Growth Rate (Decline)
(Non-U.S. GAAP) (6)

2026

2025

Biologics

$729.3

$557.0

30.9 %

3.3 %

27.6 %

Pharma

415.6

379.1

9.6 %

4.1 %

5.5 %

Generics

272.0

246.7

10.3 %

2.2 %

8.1 %

Total Proprietary Products

$1,416.9

$1,182.8

19.8 %

3.3 %

16.5 %

Reconciliation of Reported Net Sales to Organic Net Sales by Geography (6)

Three Months Ended

June 30,

Reported Net Sales
(U.S. GAAP)

Percent
Change

Impact of
Currency

Organic Net Sales
Growth Rate (Decline)
(Non-U.S. GAAP) (6)

2026

2025

Americas

$388.7

$349.7

11.2 %

0.6 %

10.6 %

Europe, Middle East, Africa

399.8

349.7

14.3 %

2.2 %

12.1 %

Asia Pacific

83.8

67.1

24.9 %

(2.1) %

27.0 %

Total

$872.3

$766.5

13.8 %

1.1 %

12.7 %

Six Months Ended

June 30,

Reported Net Sales
(U.S. GAAP)

Percent
Change

Impact of
Currency

Organic Net Sales
Growth Rate (Decline)
(Non-U.S. GAAP) (6)

2026

2025

Americas

$766.0

$688.6

11.2 %

0.5 %

10.7 %

Europe, Middle East, Africa

799.2

656.6

21.7 %

6.9 %

14.8 %

Asia Pacific

152.0

119.3

27.4 %

(0.6) %

28.0 %

Total

$1,717.2

$1,464.5

17.3 %

3.4 %

13.9 %

(6)

Organic net sales exclude the impact from acquisitions and/or divestitures and translate the current-period reported sales of subsidiaries whose functional currency is other than the U.S. Dollar at the applicable foreign currency exchange rates in effect during the comparable prior-year period.

WEST PHARMACEUTICAL SERVICES

RECONCILIATION OF NON-U.S. GAAP FINANCIAL MEASURES (UNAUDITED)

Please refer to "Non-U.S. GAAP Financial Measures" for more information

(in millions, except per share data)

Reconciliation of Reported-Diluted EPS Guidance to Adjusted-Diluted EPS Guidance

2025 Actual

2026 Guidance

% Change

Reported-diluted EPS (U.S. GAAP)

$6.79

$9.01 to $9.26

32.7% to 36.4%

Restructuring and other charges

0.31

0.23

M&A activities, including SmartDose® 3.5mL sale

0.09

(0.54) to (0.59)

Cost-method investment activity

0.06

0.05

Amortization of acquisition-related intangible assets

0.03

0.02

Other

0.01

0.08

Adjusted-diluted EPS (Non-U.S. GAAP)

$7.29

$8.85 to $9.05

21.4% to 24.1%

WEST PHARMACEUTICAL SERVICES

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(in millions, except per share data)

June 30,
2026

December 31,
2025

ASSETS

Current assets:

Cash and cash equivalents

$         435.8

$         791.3

Accounts receivable, net

712.0

574.4

Inventories

447.4

443.9

Other current assets

212.3

168.6

Total current assets

1,807.5

1,978.2

Property, plant and equipment

3,248.6

3,223.4

Less: accumulated depreciation and amortization

1,562.3

1,497.0

Property, plant and equipment, net

1,686.3

1,726.4

Operating lease right-of-use assets

104.7

117.0

Investments in affiliated companies

207.7

212.3

Goodwill

108.7

109.9

Intangible assets, net

6.4

7.7

Deferred income taxes

72.3

38.4

Other noncurrent assets

82.8

80.1

Total Assets

$       4,076.4

$       4,270.0

LIABILITIES AND EQUITY

Current liabilities:

Accounts payable

$         252.7

$         253.7

Accrued salaries, wages and benefits

97.1

135.9

Income taxes payable

64.7

28.1

Operating lease liabilities

20.9

22.7

Accrued commissions, rebates and royalties

34.0

39.2

Other current liabilities

171.1

175.3

Total current liabilities

640.5

654.9

Long-term debt

202.9

202.8

Deferred income taxes

22.4

23.0

Pension and other postretirement benefits

28.3

29.0

Operating lease liabilities

88.3

95.6

Deferred compensation benefits

13.9

13.5

Other long-term liabilities

89.9

75.2

Total Liabilities

1,086.2

1,094.0

Equity:

Preferred stock, 3.0 million shares authorized; 0 shares issued and outstanding

—

—

Common stock, par value $0.25 per share; 200.0 million shares authorized; shares
issued: June 30, 2026 - 75.3 million, December 31, 2025 - 75.3 million; shares
outstanding: June 30, 2026 - 70.4 million, December 31, 2025 - 72.0 million

18.8

18.8

Capital in excess of par value

—

—

Retained earnings

4,624.1

4,374.9

Accumulated other comprehensive loss

(140.4)

(105.5)

Treasury stock, at cost (June 30, 2026 - 4.9 million shares, December 31, 2025 -
3.3 million shares)

(1,512.3)

(1,112.2)

Total Equity

2,990.2

3,176.0

Total Liabilities and Equity

$       4,076.4

$       4,270.0

WEST PHARMACEUTICAL SERVICES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(in millions)

Six Months Ended
June 30,

2026

2025

Cash flows from operating activities:

Net income

$        292.8

$        221.6

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation

90.3

79.9

Amortization

1.1

1.5

Stock-based compensation

17.5

8.7

Non-cash restructuring charges

1.9

1.6

Asset impairments

4.2

4.1

Other non-cash items, net

(5.0)

(6.9)

Changes in assets and liabilities

(188.9)

(4.0)

Net cash provided by operating activities

213.9

306.5

Cash flows from investing activities:

Capital expenditures

(85.9)

(146.5)

Net cash used in investing activities

(85.9)

(146.5)

Cash flows from financing activities:

Borrowings under revolving credit agreements

50.0

—

Repayments under revolving credit agreements

(50.0)

—

Principal repayments on finance leases

(0.7)

(0.5)

Excise tax payments

(0.8)

(4.2)

Dividend payments

(31.5)

(30.3)

Proceeds from stock-based compensation awards

12.4

6.0

Employee stock purchase plan contributions

3.9

3.6

Shares purchased under share repurchase programs

(454.3)

(134.0)

Shares repurchased for employee tax withholdings

(2.5)

(2.5)

Net cash used in financing activities

(473.5)

(161.9)

Effect of exchange rates on cash

(10.0)

27.0

Net decrease in cash and cash equivalents

(355.5)

25.1

Cash, including cash equivalents at beginning of period

791.3

484.6

Cash, including cash equivalents at end of period

$        435.8

$        509.7

Supplemental cash flow information:

    Accrued capital expenditures

$          25.7

$          35.4

SOURCE West Pharmaceutical Services, Inc.

Key Takeaways Analysts are raising earnings estimates on Expeditors International ahead of Q2 results.The Zacks Consensus is looking for earnings to jump 13.3% in 2026.Expeditors International has a $3 billion share repurchase program and pays a dividend. Expeditors International of Washington, Inc. (EXPD - Free Report) is expected to grow earnings by the double digits in 2026 as logistics heats up. Analysts are raising earnings estimates on this Zacks Rank #1 (Strong Buy) even before it reports Q2 earnings in August 2026.

Expeditors International of Washington is a global logistics company headquartered in Bellevue, Washington. It has 171 district offices and numerous branch locations across six continents.

Services include consolidation or forwarding of air and ocean freight, customs brokerage, vendor consolidation, time-definite transportation, cargo insurance, order management, customized logistics solutions, and warehousing and distribution.

Expeditors International Expands its Aircraft on Ground (AOG) CapabilitiesOn July 20, 2026, Expeditors International of Washington announced it was expanding its global Aircraft on Ground (AOG) capabilities by bringing together logistics teams, 24/7/365 support centers and access to the company’s global network for those customers facing urgent operational disruptions.

The AOG product supports airlines, aircraft manufacturers, maintenance, repair and overhaul organizations, aerospace suppliers, defense customers, advanced air mobility providers, and others who are in the aviation industry.

This comes at a time when there is a need for specialized support during unexpected aircraft downtime, critical parts shortages, and unplanned maintenance events, as well as other operational challenges. The global air fleet is aging and requires more support.

Analysts Bullish on Expeditors International’s Earnings for Q2 2026 and FY2026Expeditors will report second quarter 2026 earnings on Aug 4, 2026. But the analysts are getting bullish ahead of the report.

One estimate has been raised for the second quarter in the last week, pushing the Zacks Consensus Estimate up to $1.68 from $1.64. This is earnings growth of 25.4% as Expeditors only made $1.34 last year.

It has beat on earnings nine quarters in a row.

For the full year, analysts are bullish as well. One estimate is higher in the last seven days, with four higher in the last month for 2026. The 2026 Zacks Consensus Estimate has jumped to $6.74 from $6.66 in the last month.

But the most accurate estimate for the full year is looking for $6.85, which is $0.09 higher than the consensus.

This is 13.3% earnings growth year-over-year as Expeditors made $5.95 in 2025.

Image Source: Zacks Investment Research

Shares of Expeditors International Near 52-Week HighsThe shares have busted out to new 5-year and 52-week highs as the earnings picture has improved.

Image Source: Zacks Investment Research

Expeditors International isn’t cheap, however. It trades with a forward price-to-earnings (P/E) ratio of 26.5. A P/E of 15 or under usually indicates value. But investors would be buying Expeditors for its growth.

It is shareholder friendly. In Feb 2026, the Board of Directors authorized a new $3 billion share repurchase program. It is also a dividend aristocrat and pays a dividend yielding 0.9%.

Since 2024, Expeditors International has returned nearly $2 billion to shareholders in the form of dividends and share repurchases.

Logistic services are heating up again. For those looking for a way to get in on this trade, Expeditors International of Washington should be on your short list.

Trump and Michael Dell have formed a strong relationship during his second term in the White House. ANDREW CABALLERO-REYNOLDS / AFP via Getty Images President Donald Trump really wants you to buy a Dell.

"You know what I say? Go out and buy a Dell computer," Trump said during an appearance on Wednesday in Marietta, Georgia. "As far as I'm concerned, that's great stuff."

It was the third time since May that the president has promoted the brand.

"They are truly incredible people. Go out and buy a Dell computer," Trump told reporters earlier in July. "I have a son that loves their laptop."

The president's run of endorsements has coincided with the Dell family's $6.25 billion donation to Trump Accounts — the new investment savings accounts for children launched by the administration in July.

"We're going to get him that money back one way or another," the president told reporters at the launch of Trump Accounts.

Shares of Dell popped as much as 9% after Trump's promotion of the brand's laptops on July 4. They traded flat on Wednesday.

Michael Dell's involvement in Trump Accounts has led to one of the more visible and steady corporate relationships of the president's second term.

Since the Dell Foundation announced its donation in December, the president has purchased more than $1 million in Dell stock. In April, he sold at least $50,000 worth of Dell shares and possibly as much as $100,000.

The growing friendship between the president and Dell has coincided with a banner year for the billionaire CEO.

Dell is now the world's 5th-richest person with a net worth of $229 billion, adding $89.1 billion in 2026 alone, according to the Bloomberg Billionaires Index. In May, his company reported its strongest quarterly earnings since its return to the public markets in 2018. Shares in Dell are up 250% so far this year.

"Michael and Susan Dell are patriots who are generously contributing billions of dollars of their fortune to the Trump Accounts of millions of kids from working-class families," White House spokesman Kush Desai previously told Business Insider earlier in July.

The president "rightfully" praised Dell and others who have donated to the program, he added.

Trump praised other wealthy donors for contributing to his child savings scheme in Georgia on Wednesday. He said that he had invoked the Dells' sizable donation to encourage a friend planning to give $50 million to contribute more.

"I said, 'That's peanuts. That's not even close to the 250 million that Michael Dell gave.' I said, 'What are you doing? You can do better than that.'"

Read next

Polly Thompson You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.

A screen displays the logo fro Cigna Corp. on the floor at the New York Stock Exchange (NYSE) in New York, U.S., July 16, 2019. REUTERS/Brendan McDermid/File Photo Purchase Licensing Rights, opens new tab

CompaniesNEW YORK, July 23 (Reuters) - Health insurer Cigna (CI.N), opens new tab said on Thursday that the artificial intelligence tools it is employing to identify patients ​with chronic or complex conditions will save customers $200 million in ‌medical costs over the next three years.

Bryan Holgerson, a president at Cigna Healthcare, said the technology should reduce occurrences of more expensive health events, as costs ​for hospitalization and emergency services continue to increase. Cigna, using ​AI tools, plans to connect more members in its ⁠health insurance business to clinicians the company employs, such as nurses.

Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.

Cigna ​said the programming will allow its 1,250 clinicians to better manage a ​patient's healthcare needs and offer customized support earlier.

The changes will boost clinical access by 20% for people with conditions like cancer and heart or kidney disease, ​Cigna said in a press release. Cigna said it expects its ​new technology to help identify breast, colorectal and lung cancer earlier.

A Cigna spokesperson said ‌company ⁠data estimates that customers using these clinical programs save $2,000 a year in medical costs.

The Cigna Group owns health insurer Cigna Healthcare, clinical business Evernorth Health Services and a pharmacy benefit manager, Express Scripts.

Rival UnitedHealth (UNH.N), opens new tab ​last week said ​tools the company ⁠has introduced this year have reduced the administrative burden for clinicians it employs through its Optum health ​services unit and increased the amount of time providers ​can spend ⁠treating patients.

CVS Health (CVS.N), opens new tab last week announced it plans to launch an AI assistant to call providers directly and book appointments on behalf of ⁠members.

Reporting by Amina Niasse; Editing by Will Dunham

Our Standards: The Thomson Reuters Trust Principles., opens new tab

D.R. Horton is upgraded from sell to hold as execution offsets weak demand and valuation concerns. Orders per community are declining, cancellations are rising, and management has lowered FY2026 guidance, highlighting ongoing demand softness. DHI's inventory management, reduced construction costs, and controlled-lot strategy are mitigating margin and balance sheet risks.

Posted by Defense World Staff on Jul 23rd, 2026

ABN Amro Investment Solutions decreased its stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 59.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 63,821 shares of the company’s stock after selling 93,474 shares during the quarter. ABN Amro Investment Solutions’ holdings in Corteva were worth $5,342,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the stock. Drummond Knight Asset Management Pty Ltd acquired a new stake in shares of Corteva during the 4th quarter worth about $25,713,000. Arbejdsmarkedets Tillaegspension acquired a new position in Corteva in the 4th quarter valued at about $23,679,000. Mirae Asset Global Investments Co. Ltd. grew its stake in Corteva by 23.5% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,075 shares of the company’s stock valued at $7,378,000 after buying an additional 20,957 shares during the last quarter. Leonteq Securities AG bought a new position in Corteva in the 4th quarter valued at about $2,350,000. Finally, Brandes Investment Partners LP lifted its position in Corteva by 1.1% during the fourth quarter. Brandes Investment Partners LP now owns 2,312,515 shares of the company’s stock worth $155,009,000 after acquiring an additional 24,985 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Wall Street Analyst Weigh In CTVA has been the subject of a number of research analyst reports. Wells Fargo & Company boosted their price objective on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Barclays lifted their price target on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Jefferies Financial Group boosted their price target on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Morgan Stanley upped their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Finally, BNP Paribas Exane boosted their target price on shares of Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.90.

Discover more

Military satellite technology

Defense industry events

Business Finance

Check Out Our Latest Research Report on CTVA

Corteva Price Performance Shares of NYSE:CTVA opened at $88.56 on Thursday. The firm has a 50 day moving average of $81.13 and a 200-day moving average of $78.69. The stock has a market capitalization of $59.23 billion, a PE ratio of 52.09, a PEG ratio of 2.64 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $88.57.

Corteva (NYSE:CTVA – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same quarter last year, the business posted $1.13 EPS. The firm’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities research analysts predict that Corteva, Inc. will post 3.75 EPS for the current fiscal year.

Corteva Announces Dividend The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Monday, June 1st. Corteva’s payout ratio is currently 42.35%.

Corteva Profile (Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Featured Articles Five stocks we like better than Corteva Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINE6,000 Shares in American Tower Corporation $AMT Bought by AR Asset Management Inc.

Stronger inflows into the investment firm's private-equity business offset a slowdown in private credit, where individual investors have pulled back.

Posted by Defense World Staff on Jul 23rd, 2026

Bank of New York Mellon Corp raised its position in shares of Zscaler, Inc. (NASDAQ:ZS – Free Report) by 7.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 494,734 shares of the company’s stock after buying an additional 36,420 shares during the quarter. Bank of New York Mellon Corp owned about 0.31% of Zscaler worth $69,406,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Qsemble Capital Management LP boosted its position in shares of Zscaler by 105.5% in the 4th quarter. Qsemble Capital Management LP now owns 15,773 shares of the company’s stock worth $3,548,000 after purchasing an additional 8,099 shares in the last quarter. Oxbow Advisors LLC bought a new position in shares of Zscaler during the fourth quarter valued at $2,939,000. J. Safra Sarasin Holding AG raised its position in shares of Zscaler by 94.7% in the 4th quarter. J. Safra Sarasin Holding AG now owns 63,627 shares of the company’s stock worth $14,311,000 after purchasing an additional 30,952 shares during the last quarter. Leonteq Securities AG bought a new position in Zscaler in the 4th quarter worth about $4,571,000. Finally, Norges Bank purchased a new stake in Zscaler during the 4th quarter valued at about $79,762,000. 46.45% of the stock is owned by hedge funds and other institutional investors.

Zscaler Stock Down 4.3% ZS stock opened at $142.26 on Thursday. Zscaler, Inc. has a twelve month low of $114.63 and a twelve month high of $336.99. The company has a quick ratio of 1.86, a current ratio of 1.86 and a debt-to-equity ratio of 0.72. The stock has a market cap of $23.00 billion, a P/E ratio of -296.37, a PEG ratio of 85.23 and a beta of 0.96. The business’s 50-day moving average price is $143.71 and its 200-day moving average price is $157.52.

Zscaler (NASDAQ:ZS – Get Free Report) last announced its quarterly earnings data on Tuesday, May 26th. The company reported $1.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.01 by $0.07. Zscaler had a negative return on equity of 0.37% and a negative net margin of 2.44%.The company had revenue of $850.48 million during the quarter, compared to the consensus estimate of $835.14 million. During the same period in the previous year, the company posted $0.84 EPS. The firm’s revenue was up 25.4% on a year-over-year basis. Zscaler has set its Q4 2026 guidance at 1.080-1.090 EPS and its FY 2026 guidance at 4.100-4.110 EPS. On average, equities research analysts forecast that Zscaler, Inc. will post 0.12 EPS for the current year.

Insider Activity In related news, CEO Jagtar Singh Chaudhry sold 2,878 shares of the company’s stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of $126.43, for a total value of $363,865.54. Following the completion of the transaction, the chief executive officer owned 343,038 shares of the company’s stock, valued at approximately $43,370,294.34. This represents a 0.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Robert Schlossman sold 3,146 shares of the company’s stock in a transaction on Tuesday, June 16th. The stock was sold at an average price of $126.43, for a total transaction of $397,748.78. Following the completion of the transaction, the insider directly owned 69,366 shares of the company’s stock, valued at $8,769,943.38. This represents a 4.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders sold 15,766 shares of company stock valued at $1,978,587. 17.20% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth Several brokerages have issued reports on ZS. Needham & Company LLC reaffirmed a “buy” rating and issued a $180.00 target price on shares of Zscaler in a report on Wednesday, June 10th. The Goldman Sachs Group restated a “neutral” rating and issued a $179.00 price objective on shares of Zscaler in a report on Wednesday, May 27th. Wedbush reissued an “outperform” rating and issued a $220.00 target price on shares of Zscaler in a report on Wednesday, June 10th. JPMorgan Chase & Co. decreased their price target on Zscaler from $250.00 to $205.00 and set an “overweight” rating for the company in a research note on Wednesday, May 27th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of Zscaler in a report on Wednesday, May 27th. Thirty-four equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $214.21.

Get Our Latest Analysis on ZS

Zscaler Profile (Free Report)

Zscaler is a cloud security company that delivers a cloud-native platform to protect users, applications and data as organizations move away from traditional, network-centric security architectures. The company focuses on a zero trust approach that assumes no implicit trust for users or devices, providing secure access to the internet, SaaS applications and private applications regardless of where users are located. Zscaler positions its services as an alternative to legacy appliances and site-centric VPNs, aiming to simplify security while enabling modern, distributed workforces.

Key offerings are built around the Zscaler Zero Trust Exchange, a multi-tenant cloud platform that enforces security and access policies in-line.

Featured Stories Five stocks we like better than Zscaler Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play Want to see what other hedge funds are holding ZS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zscaler, Inc. (NASDAQ:ZS – Free Report).

Receive News & Ratings for Zscaler Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zscaler and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBank of New York Mellon Corp Reduces Position in iShares Russell 2000 Growth ETF $IWO

NEXT HEADLINE »Fifth Third Bancorp Purchases New Shares in iShares MSCI UAE ETF $UAE

Ondas (NASDAQ:ONDS) has assembled a system-of-systems autonomous-defense portfolio that looks increasingly like something a prime would rather own than compete with. The company reported Q1 FY2026 revenue of $50.12 million (+1,079.8% year over year), lifted its FY2026 revenue target to at least $390 million, and disclosed a pro forma backlog of $457 million. With counter-UAS (Sentrycs, Iron Drone), loitering munitions (Mistral, Rotron), stratospheric ISR (World View), and a SkyWeaver agentic-AI platform co-developed with Palantir, the strategic logic for a takeout is compelling. Here are four likely acquirers, ranked from longest shot to cleanest fit.

4. Lockheed Martin: The Longest Shot Lockheed Martin (NYSE:LMT | LMT Price Prediction) carries a $119 billion market cap and has a $194 billion backlog. Jim Taiclet’s framework agreements target 3 to 4x production increases in PAC-3, THAAD, and PrSM. Lockheed invests directly in the autonomy ecosystem (PDW, World View, Firestorm Labs) but prefers building in-house. A bolt-on of Ondas’ size barely moves the needle on a prime this large.

3. Motorola Solutions: The Non-Obvious Buyer Motorola Solutions (NYSE:MSI) is the wild card. Its Silvus mesh-networking acquisition and $78 million in Silvus orders for German unmanned systems position Motorola Solutions squarely in unmanned comms. Ondas’ Iron Drone and Sentrycs would extend public-safety adjacencies into deployments like the 2026 FIFA World Cup and Davos. Real fit, but Motorola Solutions is not a traditional weapons prime.

2. RTX: Strong Strategic Fit, Scale Mismatch RTX (NYSE:RTX) has a $263 billion market cap and a $271 billion backlog. Raytheon’s Coyote, KuRFS, and Patriot programs mesh naturally with Sentrycs, Iron Drone, and Bird Aerospace’s laser airborne defense. Chris Calio noted “organic sales and adjusted operating profit growth across all three segments.” The drawback: Ondas is tiny relative to RTX, and RTX has leaned toward organic growth.

1. L3Harris: The Cleanest Fit L3Harris Technologies (NYSE:LHX) is the textbook acquirer. Christopher Kubasik’s “Trusted Disruptor” playbook produced the Aerojet Rocketdyne deal, and L3Harris posted a record $40.7 billion backlog with a 1.4x book-to-bill ratio in Q1. ISR, tactical comms, and Missile Solutions overlap directly with Ondas’ counter-UAS, ISR, and Mistral’s $982 million IDIQ Army loitering-munitions program. At L3Harris’s $53 billion market cap, a multi-hundred-million platform is digestible and mission-accretive.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and RTX didn't make the cut. Grab the names FREE today.

Where Private Equity Fits Defense-focused sponsors (Veritas Capital, AE Industrial, Arlington Capital) could theoretically bid, and Ondas’ approximately $1.55 billion pro forma cash position eases the financing math. But at a 45x price-to-sales ratio and with Q1 operating cash burn of $51.3 million, the LBO math is punishing. PE ranks below all four strategics as an acquirer, though a minority PIPE or growth co-invest alongside a strategic is plausible.

What to Watch Consolidation logic in autonomous defense tightens each quarter the Pentagon pours funding into counter-small UAS and layered air defense. Watch integration milestones from the five Q1 acquisitions, follow-on Army loitering-munitions awards, and whether Ondas’ backlog conversion holds. If Brock delivers on the $390 million revenue target, the “in play” conversation moves from speculative to structural.

Ondas shares trade at $8.00, against a mean analyst target of $19.81.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and RTX didn't make the cut. Grab the names FREE today.

Contact [email protected] for any questions or corrections.

Posted by Defense World Staff on Jul 23rd, 2026

Andra AP fonden acquired a new position in Waste Management, Inc. (NYSE:WM – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 18,182 shares of the business services provider’s stock, valued at approximately $4,178,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in Waste Management by 1.4% in the 4th quarter. Vanguard Group Inc. now owns 38,990,067 shares of the business services provider’s stock valued at $8,566,508,000 after acquiring an additional 553,605 shares during the last quarter. State Street Corp raised its holdings in shares of Waste Management by 1.6% in the 4th quarter. State Street Corp now owns 17,390,748 shares of the business services provider’s stock valued at $3,820,921,000 after purchasing an additional 281,456 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Waste Management by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 8,993,006 shares of the business services provider’s stock worth $1,972,371,000 after buying an additional 117,476 shares during the period. Norges Bank bought a new stake in Waste Management during the fourth quarter valued at about $1,022,916,000. Finally, Northern Trust Corp boosted its holdings in shares of Waste Management by 0.3% in the 3rd quarter. Northern Trust Corp now owns 3,954,519 shares of the business services provider’s stock valued at $873,276,000 after buying an additional 11,688 shares in the last quarter. 80.40% of the stock is owned by hedge funds and other institutional investors.

Waste Management Stock Up 1.5% WM stock opened at $236.69 on Thursday. Waste Management, Inc. has a one year low of $194.11 and a one year high of $248.13. The company has a debt-to-equity ratio of 2.22, a quick ratio of 0.89 and a current ratio of 0.93. The firm has a market cap of $95.05 billion, a PE ratio of 34.25, a PEG ratio of 2.84 and a beta of 0.44. The firm’s 50 day moving average price is $223.42 and its 200-day moving average price is $226.86.

Waste Management (NYSE:WM – Get Free Report) last issued its quarterly earnings data on Tuesday, April 28th. The business services provider reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.06. The firm had revenue of $6.23 billion during the quarter, compared to the consensus estimate of $6.28 billion. Waste Management had a return on equity of 31.90% and a net margin of 10.99%.The company’s quarterly revenue was up 3.5% on a year-over-year basis. During the same period last year, the company earned $1.67 EPS. On average, equities research analysts anticipate that Waste Management, Inc. will post 8.15 EPS for the current year.

Waste Management Dividend Announcement The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Friday, June 5th were paid a $0.945 dividend. The ex-dividend date of this dividend was Friday, June 5th. This represents a $3.78 annualized dividend and a dividend yield of 1.6%. Waste Management’s dividend payout ratio (DPR) is presently 54.70%.

Wall Street Analysts Forecast Growth Several research analysts recently weighed in on the company. Citigroup boosted their target price on Waste Management from $263.00 to $269.00 and gave the stock a “buy” rating in a research note on Friday, July 10th. Barclays upped their price target on shares of Waste Management from $266.00 to $270.00 and gave the company an “overweight” rating in a report on Thursday, April 30th. Oppenheimer cut their target price on shares of Waste Management from $264.00 to $263.00 and set an “outperform” rating for the company in a report on Wednesday, July 8th. Scotiabank increased their price target on Waste Management from $250.00 to $260.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 16th. Finally, Wells Fargo & Company decreased their price objective on shares of Waste Management from $273.00 to $268.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, Waste Management currently has an average rating of “Moderate Buy” and a consensus target price of $256.74.

Read Our Latest Stock Report on WM

Waste Management News Summary Here are the key news stories impacting Waste Management this week:

Positive Sentiment: A Seeking Alpha piece highlighted Waste Management as a defensive name with a positive outlook, suggesting investors may still view WM as a stable anchor in uncertain markets. Waste Management: Positive Outlook As Defensive Anchor Remains Neutral Sentiment: Analysts said WM’s earnings are expected to grow, but also noted the stock may not have the setup for a clear earnings beat, which keeps expectations balanced ahead of the next report. Waste Management (WM) Earnings Expected to Grow: Should You Buy? Neutral Sentiment: Another earnings preview from Zacks struck a similar tone, saying investors should be prepared for growth but not necessarily a strong upside surprise. Waste Management (WM) Earnings Expected to Grow: Should You Buy? Negative Sentiment: WM fell as the broader market moved higher, indicating some near-term profit-taking or relative weakness versus the market. Waste Management (WM) Stock Sinks As Market Gains: What You Should Know Negative Sentiment: A local report said Waste Management will end service in a Centre County township, which could slightly weigh on sentiment even if the business impact is limited. Waste Management to end service in a Centre County township About Waste Management (Free Report)

Waste Management, Inc (NYSE: WM) is a leading provider of integrated waste management and environmental services in North America. The company offers end-to-end solutions that span collection, transfer, disposal and recycling, along with landfill operations and related infrastructure. Headquartered in Houston, Texas, Waste Management serves a broad customer base that includes residential, commercial, industrial and municipal clients.

Core services include curbside and commercial waste collection, roll-off and temporary container services, materials recovery and recycling, and engineered landfill disposal.

Recommended Stories Five stocks we like better than Waste Management Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play Want to see what other hedge funds are holding WM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waste Management, Inc. (NYSE:WM – Free Report).

Receive News & Ratings for Waste Management Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waste Management and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAmphenol Corporation $APH Shares Bought by ABN Amro Investment Solutions

Broader AI adoption improves productivity across asset recovery and enterprise operations

, /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading company specializing in financial technology and artificial intelligence innovation across multiple industries in China and global markets, today announced measurable operating efficiency improvements as it continues to deploy AI agents across core enterprise workflows. Broader AI adoption is reducing manual intervention, increasing workforce productivity and creating greater operating leverage by automating high-volume processes across multiple business functions.

These deployments are a key component of Yiren Digital's "All-in-AI" strategy and its broader transition from AI-assisted productivity toward agent-driven execution. By embedding AI agents into core workflows, the Company is creating reusable operating capabilities that can be deployed across its businesses, supporting greater efficiency and reducing the cost of extending automation into new functions.

"Our objective is not simply to automate individual tasks, but to fundamentally improve how work is performed across the enterprise," said Mr. Ning Tang, Chairman and Chief Executive Officer of Yiren Digital. "As AI agents take on more of our high-volume, demanding workflows, the productivity gains are becoming a structural part of how we run the business, not a one-time efficiency project. We will continue to deepen AI integration across our existing businesses while extending reusable capabilities into additional verticals."

The AI deployments are supported by the Company's proprietary enterprise AI architecture, including MagiCube 2.0, its upgraded multi-agent platform. The platform provides common infrastructure for agents deployed across marketing, customer service, capital operations, risk management, compliance and research and development, with more than 10 reusable foundational capabilities, supporting enterprise-wide execution.

Measurable Operating Impact

Lower manual intervention: The human handling rate in asset-recovery operations decreased from 45.0% to 24.9%, representing a 20.1-percentage-point decline, an approximately 44.6% relative reduction in manual intervention.

Higher staff productivity: The number of service tickets handled per asset-recovery staff member within the applicable Month 1 workflow increased from 358 to 525, an improvement of approximately 47%.

Expanded agent adoption: AI agents accounted for 81% of service tickets within eligible Day 1 asset-recovery workflows in 2025, up from 50% in 2024. The Company also deployed AI agents selectively in later-stage workflows, accounting for 20% of eligible service tickets at Day 4, 14% at Day 16 and 20% at Month 2. Each percentage is calculated separately for the relevant stage and should not be interpreted as a sequential adoption trend.

Enterprise-wide reuse: MagiCube 2.0 supports agent deployment across six enterprise functions, allowing the Company to apply common AI capabilities to a broader range of regulated and high-volume workflows.

Enterprise-scale AI execution: The Fengchao AI voice agent processes approximately 1,500 hours of real-time speech-to-text activity each day. The LingShu intelligent marketing platform executes more than 1,700 tasks daily and generates individualized communication content in an average of 0.6 seconds.

Building Enterprise Operating Leverage Through AI

As AI deployment expands across the enterprise, Yiren Digital is increasingly shifting repetitive, high-volume tasks from human-assisted processes toward agent-driven execution. By combining AI agents with centralized orchestration and governance, the Company is improving operating consistency, strengthening workforce productivity and creating reusable capabilities that increase operating leverage as AI is deployed across additional business functions.

Yiren Digital plans to continue expanding agent-driven workflows across its credit and insurance operations, as part of its ongoing All-in-AI strategy, while strengthening the shared architecture and governance that support enterprise-wide AI deployment. These capabilities are designed to scale across multiple use cases and provide a foundation for the Company's broader expansion into AI application-layer opportunities, including AI entertainment and AI-assisted language learning.

About Yiren Digital

Yiren Digital Ltd. is a leading company specializing in financial technology and artificial intelligence innovation across multiple industries in China and global markets. The Company leverages advanced artificial intelligence and emerging technologies to enhance customer experience, optimize capital efficiency, and expand financial inclusion. Following the regulatory filing of its in-house developed Large Language Model Zhiyu, and the significant enhancement of its MagiCube Agent platform, Yiren Digital is establishing a new growth engine to accelerate its evolution into an AI-native, multi-industry operating platform extending beyond traditional financial services. For more information, please visit https://ir.yiren.com.

Safe Harbor Statement

This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "aim," "anticipate," "believe," "estimate," "expect," "hope," "going forward," "intend," "ought to," "plan," "project," "potential," "seek," "may," "might," "can," "could," "will," "would," "shall," "should," "is likely to" and the negative form of these words and other similar expressions. This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "target," "confident," and similar expressions. Forward-looking statements are based on management's current expectations, assumptions, and assessments of current market and operating conditions. These statements involve inherent risks, uncertainties, and other factors, many of which are outside the control of the Company, and which could cause actual results to differ materially from those expressed or implied in such statements. Actual results may differ materially from those expressed or implied in forward-looking statements due to a variety of factors and other risks described in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements speak only as of the date of this press release. The Company undertakes no, and expressly disclaims any, obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable law.

SOURCE Yiren Digital Ltd.

Posted by Defense World Staff on Jul 23rd, 2026

ABN Amro Investment Solutions cut its holdings in Capital One Financial Corporation (NYSE:COF – Free Report) by 36.1% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 49,834 shares of the financial services provider’s stock after selling 28,168 shares during the quarter. ABN Amro Investment Solutions’ holdings in Capital One Financial were worth $9,091,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Evolution Wealth Management Inc. increased its position in Capital One Financial by 529.4% during the 4th quarter. Evolution Wealth Management Inc. now owns 107 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 90 shares in the last quarter. VSM Wealth Advisory LLC acquired a new position in Capital One Financial in the 4th quarter valued at $27,000. Cherry Tree Wealth Management LLC raised its holdings in Capital One Financial by 1,312.5% in the 4th quarter. Cherry Tree Wealth Management LLC now owns 113 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 105 shares during the last quarter. Strive Asset Management LLC purchased a new position in shares of Capital One Financial during the 3rd quarter worth $28,000. Finally, Frazier Financial Advisors LLC purchased a new position in shares of Capital One Financial during the 1st quarter worth $29,000. 89.84% of the stock is currently owned by institutional investors and hedge funds.

Capital One Financial News Summary Here are the key news stories impacting Capital One Financial this week:

Positive Sentiment: Capital One beat Q2 estimates with adjusted EPS of $5.81 and revenue of about $15.8 billion, helped by stronger net interest income, higher revenues, and lower provisions for credit losses. Capital One’s Q2 Earnings Beat on Higher Revenues, Lower Provisions Positive Sentiment: Management said the Discover integration remains on schedule, synergies are being captured, and card growth could reaccelerate after platform migrations. COF Q2 Earnings Call Tracks Discover Integration Progress Positive Sentiment: Unusual options activity leaned bullish, with call buying running well above normal volume ahead of the earnings reaction. Neutral Sentiment: Some coverage framed the stock as a potential value play after solid consumer-credit results, but with investors still waiting for clearer signs on the outlook. Negative Sentiment: Shares are under pressure because the earnings beat was boosted by a sharp drop in provisions and a reserve release, while charge-offs remained elevated and integration-related expenses rose. Negative Sentiment: Deposits were weaker, and non-interest expense increased, which may temper enthusiasm about the durability of earnings momentum. Negative Sentiment: A New York lawsuit involving Zelle’s parent, Early Warning Services, could add headline risk for Capital One because COF is one of the seven bank owners, though the case is not directly about Capital One’s core operations. Zelle must face New York attorney general lawsuit over ‘rampant’ fraud, judge rules Analyst Upgrades and Downgrades A number of equities research analysts have recently commented on the company. TD Cowen lowered their price objective on Capital One Financial from $260.00 to $253.00 and set a “buy” rating for the company in a research report on Tuesday, July 7th. UBS Group increased their target price on Capital One Financial from $270.00 to $275.00 and gave the stock a “buy” rating in a research report on Tuesday, July 7th. Weiss Ratings reissued a “hold (c)” rating on shares of Capital One Financial in a research note on Wednesday, June 24th. JPMorgan Chase & Co. lifted their price target on Capital One Financial from $215.00 to $245.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Finally, Rothschild & Co Redburn lowered their price target on Capital One Financial from $290.00 to $275.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Twenty research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, Capital One Financial has a consensus rating of “Moderate Buy” and a consensus target price of $259.82.

View Our Latest Stock Report on Capital One Financial

Capital One Financial Price Performance COF stock opened at $201.84 on Thursday. The stock has a 50-day moving average price of $194.79 and a two-hundred day moving average price of $200.88. Capital One Financial Corporation has a 12-month low of $174.24 and a 12-month high of $259.64. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.46. The company has a market cap of $125.60 billion, a PE ratio of 12.49, a price-to-earnings-growth ratio of 0.75 and a beta of 1.02.

Capital One Financial (NYSE:COF – Get Free Report) last released its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $5.81 earnings per share for the quarter, beating the consensus estimate of $4.79 by $1.02. Capital One Financial had a return on equity of 11.29% and a net margin of 13.37%.The business had revenue of $15.83 billion for the quarter, compared to analyst estimates of $15.76 billion. During the same period in the previous year, the company posted $5.48 EPS. The company’s revenue was up 26.9% compared to the same quarter last year. As a group, research analysts predict that Capital One Financial Corporation will post 19.54 EPS for the current year.

Capital One Financial Announces Dividend The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Shareholders of record on Tuesday, May 19th were paid a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a yield of 1.6%. The ex-dividend date was Tuesday, May 19th. Capital One Financial’s payout ratio is currently 112.28%.

Insider Buying and Selling at Capital One Financial In other news, General Counsel Matthew W. Cooper sold 3,500 shares of the firm’s stock in a transaction on Tuesday, July 7th. The shares were sold at an average price of $208.00, for a total value of $728,000.00. Following the transaction, the general counsel owned 90,194 shares of the company’s stock, valued at approximately $18,760,352. This trade represents a 3.74% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Celia Karam sold 1,749 shares of the stock in a transaction on Friday, May 1st. The shares were sold at an average price of $192.58, for a total value of $336,822.42. Following the completion of the sale, the insider owned 61,579 shares of the company’s stock, valued at approximately $11,858,883.82. This represents a 2.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 8,749 shares of company stock valued at $1,708,577 in the last three months. Company insiders own 0.78% of the company’s stock.

Capital One Financial Company Profile (Free Report)

Capital One Financial Corporation (NYSE: COF) is a diversified bank holding company headquartered in McLean, Virginia. The company’s core businesses include credit card lending, consumer and commercial banking, and auto finance. Capital One issues a wide range of credit card products for consumers and small businesses, and it operates deposit and digital banking services aimed at retail customers and small to midsize enterprises.

Products and services include credit and charge cards, checking and savings accounts (including the online-focused Capital One 360 platform), auto loans, and commercial lending solutions.

Read More Five stocks we like better than Capital One Financial Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Capital One Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capital One Financial and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEABN Amro Investment Solutions Raises Position in Fifth Third Bancorp $FITB

NEXT HEADLINE »Aureus Asset Management LLC Has $56.91 Million Position in The Charles Schwab Corporation $SCHW

Posted by Defense World Staff on Jul 23rd, 2026

Bank of New York Mellon Corp cut its position in Rambus, Inc. (NASDAQ:RMBS – Free Report) by 28.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 779,878 shares of the semiconductor company’s stock after selling 314,278 shares during the quarter. Bank of New York Mellon Corp owned about 0.72% of Rambus worth $67,093,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Acumen Wealth Advisors LLC bought a new position in shares of Rambus in the fourth quarter worth approximately $25,000. Torren Management LLC purchased a new stake in shares of Rambus in the 4th quarter worth approximately $26,000. Spire Wealth Management raised its position in shares of Rambus by 199.0% in the 4th quarter. Spire Wealth Management now owns 302 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 201 shares during the last quarter. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Rambus in the 4th quarter worth $28,000. Finally, IFP Advisors Inc grew its stake in shares of Rambus by 126.7% in the third quarter. IFP Advisors Inc now owns 442 shares of the semiconductor company’s stock worth $47,000 after acquiring an additional 247 shares during the period. 88.54% of the stock is currently owned by institutional investors.

Rambus Price Performance NASDAQ RMBS opened at $103.83 on Thursday. The stock has a market capitalization of $11.23 billion, a P/E ratio of 49.44 and a beta of 1.84. The firm’s 50-day moving average is $129.94 and its two-hundred day moving average is $114.38. Rambus, Inc. has a 12 month low of $62.81 and a 12 month high of $174.10.

Rambus (NASDAQ:RMBS – Get Free Report) last released its quarterly earnings results on Monday, April 27th. The semiconductor company reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.61 by $0.02. The firm had revenue of $180.19 million for the quarter, compared to the consensus estimate of $179.94 million. Rambus had a return on equity of 17.41% and a net margin of 31.90%. As a group, analysts anticipate that Rambus, Inc. will post 2.44 EPS for the current year.

Insiders Place Their Bets In related news, Director Meera Rao sold 2,972 shares of the stock in a transaction on Friday, April 24th. The stock was sold at an average price of $150.30, for a total value of $446,691.60. Following the completion of the sale, the director directly owned 19,974 shares in the company, valued at approximately $3,002,092.20. This represents a 12.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Xianzhi Sean Fan sold 37,914 shares of the business’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $151.69, for a total transaction of $5,751,174.66. Following the completion of the transaction, the executive vice president owned 168,358 shares in the company, valued at $25,538,225.02. This represents a 18.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 65,886 shares of company stock worth $10,171,466. 0.75% of the stock is owned by insiders.

Analyst Upgrades and Downgrades A number of brokerages have recently issued reports on RMBS. Evercore reissued an “outperform” rating and set a $172.00 price objective on shares of Rambus in a research report on Tuesday, April 28th. Wells Fargo & Company raised their price objective on Rambus from $115.00 to $145.00 and gave the company an “overweight” rating in a research note on Tuesday, April 28th. Robert W. Baird downgraded shares of Rambus from an “outperform” rating to a “neutral” rating and set a $120.00 price objective for the company. in a research note on Tuesday, April 28th. Benchmark initiated coverage on shares of Rambus in a report on Wednesday, July 15th. They set a “buy” rating and a $165.00 price objective for the company. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Rambus in a research report on Friday, June 5th. Two equities research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $134.75.

Get Our Latest Analysis on Rambus

About Rambus (Free Report)

Rambus Inc is a technology licensing company specializing in semiconductor and system-level interface solutions. Founded in 1990 by Stanford University researchers Mike Farmwald and Mark Horowitz, Rambus established its headquarters in Sunnyvale, California. The company initially gained prominence by developing high-speed DRAM interface technology and securing a broad patent portfolio covering memory architecture, data signaling and power management innovations.

Today, Rambus licenses its proprietary intellectual property (IP) to semiconductor companies, original equipment manufacturers (OEMs) and system integrators worldwide.

Read More Five stocks we like better than Rambus Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play Want to see what other hedge funds are holding RMBS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rambus, Inc. (NASDAQ:RMBS – Free Report).

Receive News & Ratings for Rambus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rambus and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEArthur J. Gallagher & Co. (AJG) to Post Earnings on Thursday